| 1 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 2 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| 3 |
ClinicalTrials.gov (NCT03474107) An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301). U.S.National Institutes of Health.
|
| 4 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
|
| 5 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034572)
|
| 6 |
Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
|
| 7 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000838)
|
| 8 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 9 |
ClinicalTrials.gov (NCT01221870) Tesetaxel as First-line Therapy for Metastatic Breast Cancer. U.S. National Institutes of Health.
|
| 10 |
Clinical pipeline report, company report or official report of Sesen Bio.
|
| 11 |
ClinicalTrials.gov (NCT04383938) Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies. U.S. National Institutes of Health.
|
| 12 |
ClinicalTrials.gov (NCT04040725) Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression. U.S. National Institutes of Health.
|
| 13 |
ClinicalTrials.gov (NCT01413087) Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma. U.S. National Institutes of Health.
|
| 14 |
ClinicalTrials.gov (NCT01094496) A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study). U.S. National Institutes of Health.
|
| 15 |
ClinicalTrials.gov (NCT04525131) Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors. U.S. National Institutes of Health.
|
| 16 |
ClinicalTrials.gov (NCT04492293) An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer. U.S. National Institutes of Health.
|
| 17 |
ClinicalTrials.gov (NCT03719300) Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC. U.S. National Institutes of Health.
|
| 18 |
ClinicalTrials.gov (NCT01687244) Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer. U.S. National Institutes of Health.
|
| 19 |
ClinicalTrials.gov (NCT03980041) Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275). U.S. National Institutes of Health.
|
| 20 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024862)
|
| 21 |
ClinicalTrials.gov (NCT02423590) Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers. U.S. National Institutes of Health.
|
| 22 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7414).
|
| 23 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800039425)
|
| 24 |
ClinicalTrials.gov (NCT03185468) Intervention of Bladder Cancer by CAR-T
|
| 25 |
ClinicalTrials.gov (NCT01858116) PET Study of Breast Cancer Patients Using [68Ga]ABY-025. U.S. National Institutes of Health.
|
| 26 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031541)
|
| 27 |
2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9.
|
| 28 |
Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors. Front Oncol. 2022 Mar 18;12:818679.
|
| 29 |
ClinicalTrials.gov (NCT01963052) ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer. U.S. National Institutes of Health.
|
| 30 |
A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors. Clin Cancer Res. 2004 Nov 1;10(21):7127-35.
|
| 31 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025521)
|
| 32 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 33 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8261).
|
| 34 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8283).
|
| 35 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001940)
|
| 36 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010227)
|
| 37 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014822)
|
| 38 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003076)
|
| 39 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031637)
|
| 40 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016289)
|
| 41 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002545)
|
| 42 |
The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
|
| 43 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2109).
|
| 44 |
URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1757).
|
| 45 |
Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.
|
| 46 |
Prospective Validation of an mRNA-based Urine Test for Surveillance of Patients with Bladder Cancer.Eur Urol. 2019 May;75(5):853-860. doi: 10.1016/j.eururo.2018.11.055. Epub 2018 Dec 12.
|
| 47 |
Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.Cancer Med. 2019 Jun;8(6):2717-2729. doi: 10.1002/cam4.2152. Epub 2019 Apr 5.
|
| 48 |
CCL18 enhances migration, invasion and EMT by binding CCR8 in bladder cancer cells.Mol Med Rep. 2019 Mar;19(3):1678-1686. doi: 10.3892/mmr.2018.9791. Epub 2018 Dec 24.
|
| 49 |
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion.J Exp Med. 2019 Nov 4;216(11):2635-2652. doi: 10.1084/jem.20190251. Epub 2019 Sep 10.
|
| 50 |
High-soluble CGA levels are associated with poor survival in bladder cancer.Endocr Connect. 2019 May 1;8(5):625-633. doi: 10.1530/EC-19-0068.
|
| 51 |
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score.PLoS One. 2019 Feb 27;14(2):e0211721. doi: 10.1371/journal.pone.0211721. eCollection 2019.
|
| 52 |
Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells.J Cell Mol Med. 2019 Dec;23(12):8128-8138. doi: 10.1111/jcmm.14683. Epub 2019 Sep 29.
|
| 53 |
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.Clin Cancer Res. 2019 Jun 15;25(12):3689-3701. doi: 10.1158/1078-0432.CCR-18-1515. Epub 2019 Mar 7.
|
| 54 |
Soluble HER3 predicts survival in bladder cancer patients.Oncol Lett. 2018 Feb;15(2):1783-1788. doi: 10.3892/ol.2017.7470. Epub 2017 Nov 22.
|
| 55 |
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.J Urol. 2000 Jul;164(1):209-13.
|
| 56 |
Activation of type 4 metabotropic glutamate receptor promotes cell apoptosis and inhibits proliferation in bladder cancer.J Cell Physiol. 2019 Mar;234(3):2741-2755. doi: 10.1002/jcp.27089. Epub 2018 Aug 26.
|
| 57 |
GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.Int Urol Nephrol. 2015 Apr;47(4):625-30. doi: 10.1007/s11255-015-0933-0. Epub 2015 Feb 26.
|
| 58 |
Analysis of the role of mutations in the KMT2D histone lysine methyltransferase in bladder cancer.FEBS Open Bio. 2019 Feb 21;9(4):693-706. doi: 10.1002/2211-5463.12600. eCollection 2019 Apr.
|
| 59 |
Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.J Clin Invest. 2020 Jan 2;130(1):404-421. doi: 10.1172/JCI130892.
|
| 60 |
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker.Int J Cancer. 2013 Dec 1;133(11):2650-61. doi: 10.1002/ijc.28280. Epub 2013 Jul 9.
|
| 61 |
Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.Carcinogenesis. 2014 Dec;35(12):2698-705. doi: 10.1093/carcin/bgu203. Epub 2014 Sep 19.
|
| 62 |
Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis.BMC Immunol. 2016 Oct 3;17(1):36. doi: 10.1186/s12865-016-0174-8.
|
| 63 |
Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer.Br J Cancer. 2006 May 22;94(10):1465-71. doi: 10.1038/sj.bjc.6603099.
|
| 64 |
N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer.EBioMedicine. 2019 Sep;47:195-207. doi: 10.1016/j.ebiom.2019.07.068. Epub 2019 Aug 10.
|
| 65 |
Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.Cancer. 2019 Mar 15;125(6):921-932. doi: 10.1002/cncr.31890. Epub 2019 Jan 2.
|
| 66 |
Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.Biomed Pharmacother. 2019 Dec;120:109490. doi: 10.1016/j.biopha.2019.109490. Epub 2019 Sep 28.
|
| 67 |
LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.Int J Cancer. 2019 Mar 15;144(6):1345-1355. doi: 10.1002/ijc.31757. Epub 2018 Nov 4.
|
| 68 |
Lymphotoxin receptor activation promotes bladder cancer in a nuclear factor-B-dependent manner.Mol Med Rep. 2015 Feb;11(2):783-90. doi: 10.3892/mmr.2014.2826. Epub 2014 Oct 30.
|
| 69 |
Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.Clin Transl Oncol. 2019 Sep;21(9):1240-1249. doi: 10.1007/s12094-019-02049-3. Epub 2019 Feb 2.
|
| 70 |
Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.J Cell Mol Med. 2020 Jan;24(2):1804-1821. doi: 10.1111/jcmm.14878. Epub 2019 Dec 10.
|
| 71 |
TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer.Br J Cancer. 2019 Mar;120(5):555-564. doi: 10.1038/s41416-019-0397-6. Epub 2019 Feb 15.
|
| 72 |
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer.Cancer Sci. 2019 Jan;110(1):458-467. doi: 10.1111/cas.13865. Epub 2018 Dec 10.
|
| 73 |
Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer.J Cell Biochem. 2019 Jan;120(1):357-367. doi: 10.1002/jcb.27387. Epub 2018 Aug 30.
|
| 74 |
MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes.Med Sci Monit. 2019 Feb 19;25:1323-1335. doi: 10.12659/MSM.913746.
|
| 75 |
Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.Cell Mol Life Sci. 2018 Mar;75(5):939-963. doi: 10.1007/s00018-017-2681-z. Epub 2017 Oct 25.
|
| 76 |
Contribution of prostate stem cell antigen variation rs2294008 to the risk of bladder cancer.Medicine (Baltimore). 2019 Apr;98(16):e15179. doi: 10.1097/MD.0000000000015179.
|
| 77 |
RalBP1 is necessary for metastasis of human cancer cell lines. Neoplasia. 2010 Dec;12(12):1003-12.
|
| 78 |
Overexpression of exchange protein directly activated by cAMP-1 (EPAC1) attenuates bladder cancer cell migration.Biochem Biophys Res Commun. 2018 Jan 1;495(1):64-70. doi: 10.1016/j.bbrc.2017.10.142. Epub 2017 Oct 28.
|
| 79 |
Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes.Sci Adv. 2019 Sep 25;5(9):eaaw6499. doi: 10.1126/sciadv.aaw6499. eCollection 2019 Sep.
|
| 80 |
RSPO3 promotes the aggressiveness of bladder cancer via Wnt/-catenin and Hedgehog signaling pathways.Carcinogenesis. 2019 Apr 29;40(2):360-369. doi: 10.1093/carcin/bgy140.
|
| 81 |
Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway.Tumori. 2019 Jun;105(3):231-242. doi: 10.1177/0300891618811280. Epub 2019 Jan 24.
|
| 82 |
Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection.Biochem Biophys Res Commun. 2011 Oct 22;414(2):344-9. doi: 10.1016/j.bbrc.2011.09.073. Epub 2011 Sep 17.
|
| 83 |
TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.Cell Death Dis. 2018 Jan 22;9(2):72. doi: 10.1038/s41419-017-0112-6.
|
| 84 |
Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines.Eur J Med Chem. 2020 Jan 1;185:111832. doi: 10.1016/j.ejmech.2019.111832. Epub 2019 Oct 31.
|
| 85 |
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.J Exp Clin Cancer Res. 2019 Feb 20;38(1):90. doi: 10.1186/s13046-019-1087-1.
|
| 86 |
RNA-Binding Protein ZFP36L1 Suppresses Hypoxia and Cell-Cycle Signaling.Cancer Res. 2020 Jan 15;80(2):219-233. doi: 10.1158/0008-5472.CAN-18-2796. Epub 2019 Sep 24.
|
| 87 |
The clinical significance of PINX1 expression in papillary thyroid carcinoma.Hum Pathol. 2018 Nov;81:176-183. doi: 10.1016/j.humpath.2018.07.004. Epub 2018 Jul 17.
|
| 88 |
Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.Oncogene. 2020 Oct;39(40):6265-6285. doi: 10.1038/s41388-019-0902-7. Epub 2019 Aug 5.
|
| 89 |
The significance of calprotectin, CD147, APOA4 and DJ-1 in non-invasive detection of urinary bladder carcinoma.Neoplasma. 2019 Nov;66(6):1019-1023. doi: 10.4149/neo_2019_190124N74. Epub 2019 Oct 8.
|
| 90 |
Implication of RAF and RKIP genes in urinary bladder cancer.Pathol Oncol Res. 2011 Jun;17(2):181-90. doi: 10.1007/s12253-010-9295-1. Epub 2010 Sep 18.
|
| 91 |
Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.Anticancer Res. 2013 May;33(5):1917-25.
|
| 92 |
The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer.Anticancer Res. 2018 May;38(5):2749-2754. doi: 10.21873/anticanres.12517.
|
| 93 |
Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.Cancer Res. 2004 Dec 15;64(24):8932-8. doi: 10.1158/0008-5472.CAN-04-0505.
|
| 94 |
Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer.Urology. 2004 Jan;63(1):177-83. doi: 10.1016/s0090-4295(03)00786-6.
|
| 95 |
Collaborative response to arsenic-contaminated soil in an Appalachian Kentucky neighborhood.J Toxicol Environ Health A. 2019;82(12):697-701. doi: 10.1080/15287394.2019.1641872. Epub 2019 Jul 15.
|
| 96 |
Caveolin-1 and dynamin-2 overexpression is associated with the progression of bladder cancer.Oncol Lett. 2019 Jul;18(1):219-226. doi: 10.3892/ol.2019.10310. Epub 2019 May 3.
|
| 97 |
Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.Cancer Sci. 2019 Sep;110(9):2806-2821. doi: 10.1111/cas.14118. Epub 2019 Jul 23.
|
| 98 |
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.Nat Med. 2019 Jul;25(7):1073-1081. doi: 10.1038/s41591-019-0499-y. Epub 2019 Jul 3.
|
| 99 |
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.Oncogene. 2006 Feb 2;25(5):769-80. doi: 10.1038/sj.onc.1209108.
|
| 100 |
FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.J Urol. 2015 Jul;194(1):223-9. doi: 10.1016/j.juro.2015.01.073. Epub 2015 Jan 23.
|
| 101 |
Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer.Technol Cancer Res Treat. 2018 Jan 1;17:1533034618769413. doi: 10.1177/1533034618769413.
|
| 102 |
BMP9 Promotes the Proliferation and Migration of Bladder Cancer Cells through Up-Regulating lncRNA UCA1.Int J Mol Sci. 2018 Apr 8;19(4):1116. doi: 10.3390/ijms19041116.
|
| 103 |
Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking.J Comput Aided Mol Des. 2019 Sep;33(9):799-815. doi: 10.1007/s10822-019-00226-8. Epub 2019 Oct 19.
|
| 104 |
Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.Cancer Manag Res. 2019 Aug 22;11:7909-7923. doi: 10.2147/CMAR.S215341. eCollection 2019.
|
| 105 |
Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.Fam Cancer. 2018 Oct;17(4):577-585. doi: 10.1007/s10689-017-0060-4.
|
| 106 |
MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8806-8812. doi: 10.26355/eurrev_201910_19275.
|
| 107 |
Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1.Oncogene. 2017 Jul 6;36(27):3868-3877. doi: 10.1038/onc.2017.13. Epub 2017 Mar 6.
|
| 108 |
Upregulation of JMJD2A promotes migration and invasion in bladder cancer through regulation of SLUG.Oncol Rep. 2019 Oct;42(4):1431-1440. doi: 10.3892/or.2019.7246. Epub 2019 Jul 23.
|
| 109 |
KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo.Dis Markers. 2019 Jul 3;2019:4824902. doi: 10.1155/2019/4824902. eCollection 2019.
|
| 110 |
The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells.J Cell Mol Med. 2011 May;15(5):1210-24. doi: 10.1111/j.1582-4934.2010.01090.x. Epub 2010 May 14.
|
| 111 |
Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.Aging (Albany NY). 2019 Dec 17;11(24):12624-12640. doi: 10.18632/aging.102591. Epub 2019 Dec 17.
|
| 112 |
Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target.Mol Oncol. 2019 Sep;13(9):1898-1912. doi: 10.1002/1878-0261.12532. Epub 2019 Jun 27.
|
| 113 |
Gene promoter methylation and cancer: An umbrella review.Gene. 2019 Aug 20;710:333-340. doi: 10.1016/j.gene.2019.06.023. Epub 2019 Jun 13.
|
| 114 |
Specifically blocking the fatty acid synthesis to inhibit the malignant phenotype of bladder cancer.Int J Biol Sci. 2019 Jun 4;15(8):1610-1617. doi: 10.7150/ijbs.32518. eCollection 2019.
|
| 115 |
SLC14A1: a novel target for human urothelial cancer.Clin Transl Oncol. 2017 Dec;19(12):1438-1446. doi: 10.1007/s12094-017-1693-3. Epub 2017 Jun 6.
|
| 116 |
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.Urol Oncol. 2019 Nov;37(11):810.e7-810.e15. doi: 10.1016/j.urolonc.2019.04.015. Epub 2019 Apr 30.
|
| 117 |
USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.J Exp Clin Cancer Res. 2019 Jun 14;38(1):259. doi: 10.1186/s13046-019-1262-4.
|
| 118 |
Wnt7a activates canonical Wnt signaling, promotes bladder cancer cell invasion, and is suppressed by miR-370-3p.J Biol Chem. 2018 May 4;293(18):6693-6706. doi: 10.1074/jbc.RA118.001689. Epub 2018 Mar 16.
|
| 119 |
Intercellular transfer of P-glycoprotein mediates the formation of stable multi-drug resistance in human bladder cancer BIU-87 cells.Biol Open. 2019 May 1;8(5):bio041889. doi: 10.1242/bio.041889.
|
| 120 |
Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer.Cancer Chemother Pharmacol. 2019 Jul;84(1):187-194. doi: 10.1007/s00280-019-03873-8. Epub 2019 May 21.
|
| 121 |
Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143.Biomed Pharmacother. 2018 Jul;103:415-420. doi: 10.1016/j.biopha.2018.03.138. Epub 2018 Apr 24.
|
| 122 |
Correction to: Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.Int J Clin Oncol. 2018 Aug;23(4):799. doi: 10.1007/s10147-018-1257-8.
|
| 123 |
Nodal regulates bladder cancer cell migration and invasion via the ALK/Smad signaling pathway.Onco Targets Ther. 2018 Oct 5;11:6589-6597. doi: 10.2147/OTT.S177514. eCollection 2018.
|
| 124 |
Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine.Prostate. 2012 Jun 15;72(9):1023-34. doi: 10.1002/pros.21508. Epub 2011 Nov 9.
|
| 125 |
Association of AKR1C3 Polymorphisms with Bladder Cancer.Urol J. 2016 Apr 16;13(2):2615-21.
|
| 126 |
Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.Sci Rep. 2018 Feb 16;8(1):3208. doi: 10.1038/s41598-018-21467-x.
|
| 127 |
NF-B suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.Sci Rep. 2017 Jan 31;7:40723. doi: 10.1038/srep40723.
|
| 128 |
Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation.Oncotarget. 2016 Jul 12;7(28):43109-43123. doi: 10.18632/oncotarget.10097.
|
| 129 |
Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gi protein/MAPK/MMP9 intracellular signaling.Oncogene. 2020 Jan;39(3):574-586. doi: 10.1038/s41388-019-0964-6. Epub 2019 Sep 10.
|
| 130 |
Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer.PLoS Pathog. 2014 Oct 30;10(10):e1004485. doi: 10.1371/journal.ppat.1004485. eCollection 2014 Oct.
|
| 131 |
Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.Oncol Rep. 2017 Nov;38(5):3137-3143. doi: 10.3892/or.2017.5988. Epub 2017 Sep 21.
|
| 132 |
ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer.Mol Med Rep. 2017 Mar;15(3):1143-1148. doi: 10.3892/mmr.2017.6141. Epub 2017 Jan 24.
|
| 133 |
Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancer.Anticancer Res. 2013 Sep;33(9):3731-7.
|
| 134 |
Induction of Mitotic Catastrophe via Inhibition of Aurora B by Ionizing Radiation With Additive of Mulberry Water Extract in Human Bladder Cancer Cells.Integr Cancer Ther. 2019 Jan-Dec;18:1534735418808586. doi: 10.1177/1534735418808586. Epub 2018 Nov 15.
|
| 135 |
PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis.Int J Biol Sci. 2018 Oct 20;14(13):1883-1891. doi: 10.7150/ijbs.27854. eCollection 2018.
|
| 136 |
Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.Urol Oncol. 2019 Aug;37(8):530.e9-530.e18. doi: 10.1016/j.urolonc.2019.05.011. Epub 2019 Jun 5.
|
| 137 |
Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells.Biosci Biotechnol Biochem. 2010;74(5):1039-44. doi: 10.1271/bbb.90934. Epub 2010 May 7.
|
| 138 |
MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8813-8822. doi: 10.26355/eurrev_201910_19276.
|
| 139 |
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer.Oncol Lett. 2017 Jul;14(1):999-1004. doi: 10.3892/ol.2017.6230. Epub 2017 May 23.
|
| 140 |
Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors.Tumour Biol. 2014 Jun;35(6):5777-86. doi: 10.1007/s13277-014-1767-6. Epub 2014 Feb 28.
|
| 141 |
miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2.J Cancer Res Clin Oncol. 2013 Jul;139(7):1189-98. doi: 10.1007/s00432-013-1392-6. Epub 2013 Apr 9.
|
| 142 |
CCL17-CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancer.J Cell Biochem. 2019 Feb;120(2):1979-1989. doi: 10.1002/jcb.27494. Epub 2018 Sep 19.
|
| 143 |
Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer.FASEB J. 2019 Jan;33(1):1374-1388. doi: 10.1096/fj.201800667R. Epub 2018 Aug 23.
|
| 144 |
Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer.Int J Biol Macromol. 2019 Feb 15;123:322-334. doi: 10.1016/j.ijbiomac.2018.11.032. Epub 2018 Nov 8.
|
| 145 |
Metformin targets a YAP1-TEAD4 complex via AMPK to regulate CCNE1/2 in bladder cancer cells.J Exp Clin Cancer Res. 2019 Aug 27;38(1):376. doi: 10.1186/s13046-019-1346-1.
|
| 146 |
CCR4 Blockade Depletes Regulatory T Cells and Prolongs Survival in a Canine Model of Bladder Cancer.Cancer Immunol Res. 2019 Jul;7(7):1175-1187. doi: 10.1158/2326-6066.CIR-18-0751. Epub 2019 Jun 3.
|
| 147 |
CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder.World J Urol. 2019 Dec;37(12):2721-2726. doi: 10.1007/s00345-018-02618-1. Epub 2019 Mar 13.
|
| 148 |
Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma.Cancer Manag Res. 2019 May 23;11:4677-4690. doi: 10.2147/CMAR.S198348. eCollection 2019.
|
| 149 |
Novel blood biomarkers of human urinary bladder cancer.Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3374-80. doi: 10.1158/1078-0432.CCR-05-2081.
|
| 150 |
Targeting immunotherapy for bladder cancer using anti-CD3 B7-H3 bispecific antibody.Cancer Med. 2018 Oct;7(10):5167-5177. doi: 10.1002/cam4.1775. Epub 2018 Sep 25.
|
| 151 |
Synergic effects of cancer stem cells markers, CD44 and embryonic stem cell transcription factor Nanog, on bladder cancer prognosis.Br J Biomed Sci. 2020 Apr;77(2):69-75. doi: 10.1080/09674845.2019.1692761. Epub 2019 Dec 20.
|
| 152 |
Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer.Int J Mol Sci. 2018 Sep 10;19(9):2694. doi: 10.3390/ijms19092694.
|
| 153 |
CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.Clin Cancer Res. 2019 Jun 15;25(12):3561-3571. doi: 10.1158/1078-0432.CCR-18-3267. Epub 2019 Mar 19.
|
| 154 |
Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells.Oncol Lett. 2018 May;15(5):7631-7638. doi: 10.3892/ol.2018.8309. Epub 2018 Mar 21.
|
| 155 |
Identification of key genes associated with bladder cancer using gene expression profiles.Oncol Lett. 2018 Jan;15(1):297-303. doi: 10.3892/ol.2017.7310. Epub 2017 Oct 31.
|
| 156 |
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.Sci Rep. 2016 Oct 24;6:35854. doi: 10.1038/srep35854.
|
| 157 |
Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer.Int J Cancer. 1997 Jun 11;71(6):986-92. doi: 10.1002/(sici)1097-0215(19970611)71:6<986::aid-ijc14>3.0.co;2-4.
|
| 158 |
Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.Anticancer Drugs. 2014 Sep;25(8):887-97. doi: 10.1097/CAD.0000000000000116.
|
| 159 |
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine.J Exp Clin Cancer Res. 2017 Jan 3;36(1):1. doi: 10.1186/s13046-016-0473-1.
|
| 160 |
Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.Biochem Biophys Res Commun. 2016 Sep 16;478(2):887-92. doi: 10.1016/j.bbrc.2016.08.046. Epub 2016 Aug 9.
|
| 161 |
Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population.Hum Mol Genet. 2015 Feb 15;24(4):1177-84. doi: 10.1093/hmg/ddu512. Epub 2014 Oct 3.
|
| 162 |
The role of Clusterin in cancer metastasis.Cancer Manag Res. 2019 Mar 27;11:2405-2414. doi: 10.2147/CMAR.S196273. eCollection 2019.
|
| 163 |
MCT1 regulates aggressive and metabolic phenotypes in bladder cancer.J Cancer. 2018 Jun 15;9(14):2492-2501. doi: 10.7150/jca.25257. eCollection 2018.
|
| 164 |
Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor (TGF-)/Smad Pathway.Med Sci Monit. 2018 Aug 1;24:5346-5354. doi: 10.12659/MSM.909811.
|
| 165 |
Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.Yonsei Med J. 2016 Jul;57(4):865-71. doi: 10.3349/ymj.2016.57.4.865.
|
| 166 |
Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1.BMB Rep. 2020 Feb;53(2):82-87. doi: 10.5483/BMBRep.2020.53.2.059.
|
| 167 |
Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.Cancer Sci. 2019 Jul;110(7):2119-2132. doi: 10.1111/cas.14080. Epub 2019 Jun 24.
|
| 168 |
Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.Biochem Pharmacol. 2006 Nov 30;72(11):1577-88. doi: 10.1016/j.bcp.2006.06.020. Epub 2006 Jul 18.
|
| 169 |
Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer.Int J Cancer. 2007 Jun 1;120(11):2452-8. doi: 10.1002/ijc.22565.
|
| 170 |
Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.Nat Rev Urol. 2018 Feb;15(2):92-111. doi: 10.1038/nrurol.2017.179. Epub 2017 Nov 14.
|
| 171 |
HR-MAS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease.J Proteome Res. 2013 Jul 5;12(7):3519-28. doi: 10.1021/pr4004135. Epub 2013 Jun 18.
|
| 172 |
Cathepsin S inhibition changes regulatory T-cell activity in regulating bladder cancer and immune cell proliferation and apoptosis.Mol Immunol. 2017 Feb;82:66-74. doi: 10.1016/j.molimm.2016.12.018. Epub 2016 Dec 26.
|
| 173 |
A quantitative proteomic analysis uncovers the relevance of CUL3 in bladder cancer aggressiveness.PLoS One. 2013;8(1):e53328. doi: 10.1371/journal.pone.0053328. Epub 2013 Jan 8.
|
| 174 |
Epithelial-mesenchymal transition induced by GRO--CXCR2 promotes bladder cancer recurrence after intravesical chemotherapy.Oncotarget. 2017 Jul 11;8(28):45274-45285. doi: 10.18632/oncotarget.16786.
|
| 175 |
Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain. Environ Health Perspect. 2010 Nov;118(11):1545-50. doi: 10.1289/ehp.1002206.
|
| 176 |
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer. Cancer Chemother Pharmacol. 2017 Sep;80(3):653-659.
|
| 177 |
High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.Chin Med J (Engl). 2000 Feb;113(2):117-9.
|
| 178 |
Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer.Clin Cancer Res. 2014 Nov 1;20(21):5435-45. doi: 10.1158/1078-0432.CCR-14-0542. Epub 2014 Sep 15.
|
| 179 |
Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.Exp Mol Pathol. 2019 Jun;108:164-172. doi: 10.1016/j.yexmp.2019.04.015. Epub 2019 Apr 25.
|
| 180 |
The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets.J Cell Physiol. 2019 Sep;234(9):15607-15618. doi: 10.1002/jcp.28208. Epub 2019 Feb 18.
|
| 181 |
Discoidin domain receptor 1 activity drives an aggressive phenotype in bladder cancer.Am J Transl Res. 2017 May 15;9(5):2500-2507. eCollection 2017.
|
| 182 |
MEK inhibition enhances efficacy of bacillus Calmette-Gurin on bladder cancer cells by reducing release of Toll-like receptor 2-activated antimicrobial peptides.Oncotarget. 2017 May 26;8(32):53168-53179. doi: 10.18632/oncotarget.18230. eCollection 2017 Aug 8.
|
| 183 |
Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case-Control Study of Patients with Head and Neck Squamous Cell Carcinoma.Transl Oncol. 2018 Feb;11(1):168-174. doi: 10.1016/j.tranon.2017.12.001. Epub 2017 Dec 28.
|
| 184 |
Bladder cancer-associated cancer-testis antigen-derived long peptides encompassing both CTL and promiscuous HLA class II-restricted Th cell epitopes induced CD4(+) T cells expressing converged T-cell receptor genes in vitro.Oncoimmunology. 2018 Jan 5;7(4):e1415687. doi: 10.1080/2162402X.2017.1415687. eCollection 2018.
|
| 185 |
Novel fusion transcripts in bladder cancer identified by RNA-seq.Cancer Lett. 2016 May 1;374(2):224-8. doi: 10.1016/j.canlet.2016.02.010. Epub 2016 Feb 16.
|
| 186 |
DHCR24 predicts poor clinicopathological features of patients with bladder cancer: A STROBE-compliant study.Medicine (Baltimore). 2018 Sep;97(39):e11830. doi: 10.1097/MD.0000000000011830.
|
| 187 |
MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway.Cell Cycle. 2018;17(24):2790-2801. doi: 10.1080/15384101.2018.1557490. Epub 2018 Dec 18.
|
| 188 |
Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.Clin Cancer Res. 2006 Aug 15;12(16):4836-44. doi: 10.1158/1078-0432.CCR-06-0285.
|
| 189 |
miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer.Int J Cancer. 2019 Jun 15;144(12):3043-3055. doi: 10.1002/ijc.32036. Epub 2019 Jan 12.
|
| 190 |
MiR-194-5p inhibits cell migration and invasion in bladder cancer by targeting E2F3.J BUON. 2018 Sep-Oct;23(5):1492-1499.
|
| 191 |
Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5.Pathol Res Pract. 2017 Sep;213(9):1059-1066. doi: 10.1016/j.prp.2017.07.029. Epub 2017 Aug 1.
|
| 192 |
A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population.Clin Cancer Res. 2008 Jun 1;14(11):3633-40. doi: 10.1158/1078-0432.CCR-07-5155.
|
| 193 |
The effect of miR-124-3p on cell proliferation and apoptosis in bladder cancer by targeting EDNRB.Arch Med Sci. 2019 Sep;15(5):1154-1162. doi: 10.5114/aoms.2018.78743. Epub 2018 Oct 3.
|
| 194 |
Differential mTOR pathway profiles in bladder cancer cell line subtypes to predict sensitivity to mTOR inhibition.Urol Oncol. 2017 Oct;35(10):593-599. doi: 10.1016/j.urolonc.2017.03.025. Epub 2017 Apr 18.
|
| 195 |
N1-guanyl-1,7-diaminoheptane sensitizes bladder cancer cells to doxorubicin by preventing epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2 activation.Cancer Sci. 2014 Feb;105(2):219-27. doi: 10.1111/cas.12328. Epub 2014 Jan 7.
|
| 196 |
Capsaicin Inhibits Multiple Bladder Cancer Cell Phenotypes by Inhibiting Tumor-Associated NADH Oxidase (tNOX) and Sirtuin1 (SIRT1).Molecules. 2016 Jun 28;21(7):849. doi: 10.3390/molecules21070849.
|
| 197 |
Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression.Med Oncol. 2016 Nov;33(11):131. doi: 10.1007/s12032-016-0836-7. Epub 2016 Oct 18.
|
| 198 |
Exploring the roles of urinary HAI-1, EpCAM & EGFR in bladder cancer prognosis & risk stratification.Oncotarget. 2018 May 18;9(38):25244-25253. doi: 10.18632/oncotarget.25397. eCollection 2018 May 18.
|
| 199 |
Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration.Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):E11701-E11710. doi: 10.1073/pnas.1804506115. Epub 2018 Nov 21.
|
| 200 |
IRE1-TRAF2-ASK1 complex-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to CXC195-induced apoptosis in human bladder carcinoma T24 cells.Biochem Biophys Res Commun. 2015 May 8;460(3):530-6. doi: 10.1016/j.bbrc.2015.03.064. Epub 2015 Mar 19.
|
| 201 |
The enhanced expression of estrogen-related receptor in human bladder cancer tissues and the effects of estrogen-related receptor knockdown on bladder cancer cells.J Cell Biochem. 2019 Aug;120(8):13841-13852. doi: 10.1002/jcb.28657. Epub 2019 Apr 11.
|
| 202 |
ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer InVitro and InVivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis.Mol Ther Nucleic Acids. 2017 Jun 16;7:299-313. doi: 10.1016/j.omtn.2017.04.012. Epub 2017 Apr 14.
|
| 203 |
Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up.BMC Cancer. 2018 Dec 10;18(1):1239. doi: 10.1186/s12885-018-5137-4.
|
| 204 |
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.Carcinogenesis. 2009 May;30(5):763-8. doi: 10.1093/carcin/bgp046. Epub 2009 Feb 23.
|
| 205 |
Disruption of the FA/BRCA pathway in bladder cancer.Cytogenet Genome Res. 2007;118(2-4):166-76. doi: 10.1159/000108297.
|
| 206 |
Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer.Ir J Med Sci. 2018 Nov;187(4):1115-1119. doi: 10.1007/s11845-018-1764-7. Epub 2018 Feb 16.
|
| 207 |
Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.J Cell Physiol. 2019 Mar;234(3):3088-3104. doi: 10.1002/jcp.27129. Epub 2018 Sep 17.
|
| 208 |
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer.J Pathol. 2003 Dec;201(4):603-8. doi: 10.1002/path.1481.
|
| 209 |
CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.Int J Mol Med. 2010 Aug;26(2):241-7. doi: 10.3892/ijmm_00000458.
|
| 210 |
MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819886897. doi: 10.1177/1533033819886897.
|
| 211 |
Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.Int J Oncol. 2013 Apr;42(4):1271-8. doi: 10.3892/ijo.2013.1807. Epub 2013 Feb 5.
|
| 212 |
Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-1 in bladder cancer cells.J Exp Clin Cancer Res. 2019 Mar 1;38(1):111. doi: 10.1186/s13046-019-1102-6.
|
| 213 |
KLF5 promotes cell migration by up-regulating FYN in bladder cancer cells.FEBS Lett. 2016 Feb;590(3):408-18. doi: 10.1002/1873-3468.12069. Epub 2016 Feb 1.
|
| 214 |
Analysis of bladder cancer subtypes in neurogenic bladder tumors.Can J Urol. 2018 Feb;25(1):9161-9167.
|
| 215 |
Nanoscale bubble delivered YCD-TK/Cx26 gene therapeutic system suppresses tumor growth by inducing necrosis of tumor tissues in mouse Xenograft bladder cancer models.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7338-7349. doi: 10.26355/eurrev_201909_18839.
|
| 216 |
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.J Cell Physiol. 2019 Nov;234(11):20634-20647. doi: 10.1002/jcp.28669. Epub 2019 Apr 22.
|
| 217 |
TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.J Cell Biochem. 2018 Feb;119(2):1791-1803. doi: 10.1002/jcb.26340. Epub 2017 Sep 11.
|
| 218 |
Gonadotropin-releasing hormone (GnRH) and GnRH receptor in bladder cancer epithelia and GnRH effect on bladder cancer cell proliferation.Urol Int. 2008;80(4):431-8. doi: 10.1159/000132703. Epub 2008 Jun 27.
|
| 219 |
Roles of ER and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen.Biomed Res Int. 2015;2015:251780. doi: 10.1155/2015/251780. Epub 2015 May 18.
|
| 220 |
Knocking down glycoprotein nonmetastatic melanoma protein B suppresses the proliferation, migration, and invasion in bladder cancer cells.Tumour Biol. 2017 Apr;39(4):1010428317699119. doi: 10.1177/1010428317699119.
|
| 221 |
GPR137 is a promising novel bio-marker for the prognosis of bladder cancer patients.Medicine (Baltimore). 2019 Aug;98(35):e16576. doi: 10.1097/MD.0000000000016576.
|
| 222 |
G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.Int J Mol Sci. 2015 Oct 14;16(10):24319-31. doi: 10.3390/ijms161024319.
|
| 223 |
ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.Cancer Res. 2013 Jun 15;73(12):3625-37. doi: 10.1158/0008-5472.CAN-12-3879. Epub 2013 Mar 27.
|
| 224 |
Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents.PLoS Biol. 2017 Nov 21;15(11):e2003460. doi: 10.1371/journal.pbio.2003460. eCollection 2017 Nov.
|
| 225 |
Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems.Int J Mol Sci. 2019 May 27;20(10):2599. doi: 10.3390/ijms20102599.
|
| 226 |
Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.J Exp Clin Cancer Res. 2014 Jul 10;33(1):59. doi: 10.1186/s13046-014-0059-8.
|
| 227 |
Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.J Cell Biochem. 2014 Oct;115(10):1762-7. doi: 10.1002/jcb.24842.
|
| 228 |
Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.Wien Klin Wochenschr. 2017 Jun;129(11-12):391-397. doi: 10.1007/s00508-016-1108-4. Epub 2016 Nov 9.
|
| 229 |
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72. doi: 10.1158/1055-9965.EPI-15-0247. Epub 2015 Jun 24.
|
| 230 |
Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.BMC Cancer. 2018 Nov 12;18(1):1088. doi: 10.1186/s12885-018-5014-1.
|
| 231 |
HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer. Int J Oncol. 2018 Aug;53(2):725-736.
|
| 232 |
Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction.Int J Mol Med. 2014 Apr;33(4):1019-26. doi: 10.3892/ijmm.2014.1649. Epub 2014 Feb 10.
|
| 233 |
Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity.Oncotarget. 2019 Oct 8;10(56):5824-5834. doi: 10.18632/oncotarget.27217. eCollection 2019 Oct 8.
|
| 234 |
Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.Oncotarget. 2018 Jan 8;9(8):7961-7974. doi: 10.18632/oncotarget.24091. eCollection 2018 Jan 30.
|
| 235 |
Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens.Oncotarget. 2018 Jul 20;9(56):30731-30747. doi: 10.18632/oncotarget.24578. eCollection 2018 Jul 20.
|
| 236 |
Overexpression of Tat-interacting protein 30 inhibits the proliferation, migration, invasion and promotes apoptosis in bladder cancer cells.J Cancer Res Ther. 2018 Sep;14(Supplement):S713-S718. doi: 10.4103/0973-1482.206869.
|
| 237 |
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer.Future Oncol. 2020 Jan;16(2):4359-4368. doi: 10.2217/fon-2019-0611. Epub 2019 Dec 11.
|
| 238 |
Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death.Int J Cancer. 2010 Aug 15;127(4):830-8. doi: 10.1002/ijc.25088.
|
| 239 |
Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway.Neoplasma. 2020 Jan;67(1):129-136. doi: 10.4149/neo_2019_190206N108. Epub 2019 Dec 17.
|
| 240 |
IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.BMC Cancer. 2017 Sep 7;17(1):636. doi: 10.1186/s12885-017-3618-5.
|
| 241 |
Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.Int J Mol Med. 2015 Aug;36(2):595-601. doi: 10.3892/ijmm.2015.2250. Epub 2015 Jun 17.
|
| 242 |
Effectiveness of two different dose administration regimens of an IL-15 superagonist complex (ALT-803) in an orthotopic bladder cancer mouse model.J Transl Med. 2019 Jan 17;17(1):29. doi: 10.1186/s12967-019-1778-6.
|
| 243 |
Association of 3 Common Polymorphisms of IL-27 Gene with Susceptibility to Cancer in Chinese: Evidence From an Updated Meta-Analysis of 27 Studies.Med Sci Monit. 2015 Aug 24;21:2505-13. doi: 10.12659/MSM.895032.
|
| 244 |
Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.PLoS One. 2012;7(9):e40267. doi: 10.1371/journal.pone.0040267. Epub 2012 Sep 4.
|
| 245 |
Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma.Oncol Lett. 2018 Oct;16(4):4325-4330. doi: 10.3892/ol.2018.9145. Epub 2018 Jul 13.
|
| 246 |
NLS-Cholic Acid Conjugation to IL-5R-Specific Antibody Improves Cellular Accumulation and In Vivo Tumor-Targeting Properties in a Bladder Cancer Model.Bioconjug Chem. 2018 Apr 18;29(4):1352-1363. doi: 10.1021/acs.bioconjchem.8b00077. Epub 2018 Mar 1.
|
| 247 |
Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.Mol Cancer. 2018 Jan 31;17(1):19. doi: 10.1186/s12943-018-0771-7.
|
| 248 |
MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5139-5148. doi: 10.26355/eurrev_201906_18178.
|
| 249 |
Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer.Urology. 2002 Sep;60(3):531-6. doi: 10.1016/s0090-4295(02)01748-x.
|
| 250 |
LncRNA ITGB1 promotes the development of bladder cancer through regulating microRNA-10a expression.Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6858-6867. doi: 10.26355/eurrev_201908_18725.
|
| 251 |
Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.Oncogene. 2005 Feb 17;24(8):1396-402. doi: 10.1038/sj.onc.1208313.
|
| 252 |
Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.BMC Cancer. 2019 Feb 11;19(1):137. doi: 10.1186/s12885-019-5353-6.
|
| 253 |
The RING domain in the anti-apoptotic protein XIAP stabilizes c-Myc protein and preserves anchorage-independent growth of bladder cancer cells.J Biol Chem. 2019 Apr 12;294(15):5935-5944. doi: 10.1074/jbc.RA118.005621. Epub 2019 Feb 28.
|
| 254 |
Connexin 26 is down-regulated by KDM5B in the progression of bladder cancer.Int J Mol Sci. 2013 Apr 11;14(4):7866-79. doi: 10.3390/ijms14047866.
|
| 255 |
KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.J Cell Physiol. 2019 Sep;234(9):16517-16525. doi: 10.1002/jcp.28322. Epub 2019 Feb 25.
|
| 256 |
Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1.PLoS One. 2014 Oct 1;9(10):e104252. doi: 10.1371/journal.pone.0104252. eCollection 2014.
|
| 257 |
MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.Oncotarget. 2017 May 16;8(20):33064-33077. doi: 10.18632/oncotarget.16524.
|
| 258 |
Rapid and quantitative detection of urinary Cyfra21-1 using fluorescent nanosphere-based immunochromatographic test strip for diagnosis and prognostic monitoring of bladder cancer.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):4266-4272. doi: 10.1080/21691401.2019.1687491.
|
| 259 |
Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.Oncol Lett. 2018 May;15(5):7923-7933. doi: 10.3892/ol.2018.8317. Epub 2018 Mar 22.
|
| 260 |
Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.Biomark Med. 2017 Apr;11(4):347-357. doi: 10.2217/bmm-2016-0348. Epub 2017 Mar 14.
|
| 261 |
Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA.Am J Transl Res. 2019 Nov 15;11(11):6838-6849. eCollection 2019.
|
| 262 |
The Lin28/let-7a/c-Myc pathway plays a role in non-muscle invasive bladder cancer.Cell Tissue Res. 2013 Nov;354(2):533-41. doi: 10.1007/s00441-013-1715-6. Epub 2013 Sep 15.
|
| 263 |
The origins of bladder cancer.Lab Invest. 2008 Jul;88(7):686-93. doi: 10.1038/labinvest.2008.48. Epub 2008 May 12.
|
| 264 |
RETRACTED: lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.Biomed Pharmacother. 2019 Jun;114:108814. doi: 10.1016/j.biopha.2019.108814. Epub 2019 Apr 4.
|
| 265 |
The IL-1RN and IL-4 gene polymorphisms are potential genetic markers of susceptibility to bladder cancer: a case-control study.World J Urol. 2015 Mar;33(3):389-95. doi: 10.1007/s00345-014-1323-4. Epub 2014 May 22.
|
| 266 |
Up-regulation of BLT2 is critical for the survival of bladder cancer cells.Exp Mol Med. 2011 Mar 31;43(3):129-37. doi: 10.3858/emm.2011.43.3.014.
|
| 267 |
LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.Br J Cancer. 2011 Jan 18;104(2):376-86. doi: 10.1038/sj.bjc.6605990. Epub 2010 Nov 9.
|
| 268 |
Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.Urology. 2006 Jun;67(6):1335-40. doi: 10.1016/j.urology.2005.12.029.
|
| 269 |
Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.Clin Cancer Res. 2001 Jan;7(1):23-31.
|
| 270 |
MEK1 and MEK2 differentially regulate human insulin- and insulin glargine-induced human bladder cancer T24 cell proliferation.Chin Med J (Engl). 2012 Dec;125(23):4197-201.
|
| 271 |
Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.Hum Pathol. 2012 Oct;43(10):1573-82. doi: 10.1016/j.humpath.2011.10.026. Epub 2012 Mar 12.
|
| 272 |
Silencing TAK1 alters gene expression signatures in bladder cancer cells.Oncol Lett. 2017 May;13(5):2975-2981. doi: 10.3892/ol.2017.5819. Epub 2017 Mar 7.
|
| 273 |
Inhibition of TPL2 by interferon- suppresses bladder cancer through activation of PDE4D.J Exp Clin Cancer Res. 2018 Nov 27;37(1):288. doi: 10.1186/s13046-018-0971-4.
|
| 274 |
Activation of cyclic AMP/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics.Urol Oncol. 2014 Jan;32(1):47.e21-8. doi: 10.1016/j.urolonc.2013.06.017. Epub 2013 Oct 17.
|
| 275 |
RhoGDI promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation.Mol Oncol. 2017 Nov;11(11):1579-1594. doi: 10.1002/1878-0261.12132. Epub 2017 Sep 11.
|
| 276 |
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.Cancer Res. 2010 Jan 15;70(2):832-41. doi: 10.1158/0008-5472.CAN-09-2918. Epub 2010 Jan 12.
|
| 277 |
Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.Investig Clin Urol. 2016 Jan;57(1):63-72. doi: 10.4111/icu.2016.57.1.63. Epub 2016 Jan 11.
|
| 278 |
Midkine promoter-based conditionally replicative adenovirus for targeting midkine-expressing human bladder cancer model.Urology. 2007 Nov;70(5):1009-13. doi: 10.1016/j.urology.2007.07.003. Epub 2007 Oct 24.
|
| 279 |
Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.BMC Cancer. 2016 Aug 2;16:578. doi: 10.1186/s12885-016-2640-3.
|
| 280 |
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.Oncogene. 2011 Feb 10;30(6):642-53. doi: 10.1038/onc.2010.446. Epub 2010 Oct 18.
|
| 281 |
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer.J Cancer Res Clin Oncol. 2018 Apr;144(4):637-644. doi: 10.1007/s00432-018-2593-9. Epub 2018 Jan 23.
|
| 282 |
MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer.Clin Cancer Res. 2014 Dec 15;20(24):6324-35. doi: 10.1158/1078-0432.CCR-13-3336. Epub 2014 Oct 17.
|
| 283 |
Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.Cancer Sci. 2016 Sep;107(9):1233-42. doi: 10.1111/cas.13002. Epub 2016 Sep 6.
|
| 284 |
Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.BJU Int. 2013 Dec;112(8):1207-14. doi: 10.1111/bju.12230. Epub 2013 Jul 2.
|
| 285 |
Transforming growth factor? induces epithelialmesenchymal transition and increased expression of matrix metalloproteinase?6 via miR?00b downregulation in bladder cancer cells.Mol Med Rep. 2014 Sep;10(3):1549-54. doi: 10.3892/mmr.2014.2366. Epub 2014 Jul 7.
|
| 286 |
Association of Matrix Metalloproteinase-8 Genotypes with the Risk of Bladder Cancer.Anticancer Res. 2018 Sep;38(9):5159-5164. doi: 10.21873/anticanres.12838.
|
| 287 |
Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer.Am J Clin Pathol. 2014 Nov;142(5):634-9. doi: 10.1309/AJCPVTCJ4VU5HKVZ.
|
| 288 |
A Whole-genome CRISPR Screen Identifies a Role of MSH2 in Cisplatin-mediated Cell Death in Muscle-invasive Bladder Cancer.Eur Urol. 2019 Feb;75(2):242-250. doi: 10.1016/j.eururo.2018.10.040. Epub 2018 Nov 7.
|
| 289 |
MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.Cancer Sci. 2019 Jul;110(7):2189-2199. doi: 10.1111/cas.14035. Epub 2019 May 27.
|
| 290 |
High CD204+ tumor-infiltrating macrophage density predicts a poor prognosis in patients with urothelial cell carcinoma of the bladder.Oncotarget. 2015 Aug 21;6(24):20204-14. doi: 10.18632/oncotarget.3887.
|
| 291 |
RON is overexpressed in bladder cancer and contributes to tumorigenic phenotypes in 5637 cells.Oncol Lett. 2018 May;15(5):6547-6554. doi: 10.3892/ol.2018.8135. Epub 2018 Feb 28.
|
| 292 |
miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.J Cell Biochem. 2019 Sep;120(9):15924-15932. doi: 10.1002/jcb.28866. Epub 2019 May 8.
|
| 293 |
Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer.Cancer Detect Prev. 2001;25(1):62-75.
|
| 294 |
Interaction of YAP1 and mTOR promotes bladder cancer progression.Int J Oncol. 2020 Jan;56(1):232-242. doi: 10.3892/ijo.2019.4922. Epub 2019 Nov 25.
|
| 295 |
Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.Biophys J. 2017 Mar 28;112(6):1246-1257. doi: 10.1016/j.bpj.2017.01.033.
|
| 296 |
Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in Gansu province of China.Oncotarget. 2016 May 24;7(21):31372-83. doi: 10.18632/oncotarget.9146.
|
| 297 |
Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.Med Sci Monit. 2017 Sep 27;23:4644-4649. doi: 10.12659/msm.901610.
|
| 298 |
Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.Cancer Lett. 2017 Sep 10;403:305-317. doi: 10.1016/j.canlet.2017.06.027. Epub 2017 Jul 4.
|
| 299 |
Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer.Bioorg Med Chem. 2017 Feb 1;25(3):1242-1249. doi: 10.1016/j.bmc.2016.12.042. Epub 2016 Dec 27.
|
| 300 |
Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer.Croat Med J. 2014 Oct;55(5):507-13. doi: 10.3325/cmj.2014.55.507.
|
| 301 |
Honokiol inhibits bladder cancer cell invasion through repressing SRC-3 expression and epithelial-mesenchymal transition.Oncol Lett. 2017 Oct;14(4):4294-4300. doi: 10.3892/ol.2017.6665. Epub 2017 Jul 25.
|
| 302 |
Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.Cancer Chemother Pharmacol. 2018 Oct;82(4):593-605. doi: 10.1007/s00280-018-3651-3. Epub 2018 Jul 21.
|
| 303 |
Targeting Nectin-4 in Bladder Cancer.Cancer Discov. 2017 Aug;7(8):OF3. doi: 10.1158/2159-8290.CD-NB2017-095. Epub 2017 Jun 20.
|
| 304 |
NRP-1 expression in bladder cancer and its implications for tumor progression.Tumour Biol. 2014 Jun;35(6):6089-94. doi: 10.1007/s13277-014-1806-3. Epub 2014 Mar 14.
|
| 305 |
NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.J Cell Biochem. 2019 Apr;120(4):6596-6604. doi: 10.1002/jcb.27954. Epub 2018 Nov 13.
|
| 306 |
Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.Cancer Biol Ther. 2019;20(4):552-561. doi: 10.1080/15384047.2018.1538613. Epub 2018 Nov 7.
|
| 307 |
Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples.Acta Pharmacol Sin. 2008 Mar;29(3):364-70. doi: 10.1111/j.1745-7254.2008.00747.x.
|
| 308 |
Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer.Carcinogenesis. 2019 Mar 12;40(1):84-92. doi: 10.1093/carcin/bgy154.
|
| 309 |
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.Nat Commun. 2018 Aug 29;9(1):3510. doi: 10.1038/s41467-018-05939-2.
|
| 310 |
The role of oncostatin M receptor gene polymorphisms in bladder cancer.World J Surg Oncol. 2019 Feb 12;17(1):30. doi: 10.1186/s12957-018-1555-7.
|
| 311 |
Clinicopathological and cellular signature of PAK1 in human bladder cancer.Tumour Biol. 2015 Apr;36(4):2359-68. doi: 10.1007/s13277-014-2843-7. Epub 2014 Nov 21.
|
| 312 |
Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.Immunobiology. 2014 Jun;219(6):469-74. doi: 10.1016/j.imbio.2014.02.003. Epub 2014 Feb 25.
|
| 313 |
PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest.Oncotarget. 2015 Jun 30;6(18):16366-78. doi: 10.18632/oncotarget.3879.
|
| 314 |
LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk.Br J Cancer. 2014 Apr 15;110(8):2123-30. doi: 10.1038/bjc.2014.67. Epub 2014 Mar 4.
|
| 315 |
Targeting of MCT1 and PFKFB3 influences cell proliferation and apoptosis in bladder cancer by altering the tumor microenvironment.Oncol Rep. 2016 Aug;36(2):945-51. doi: 10.3892/or.2016.4884. Epub 2016 Jun 16.
|
| 316 |
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.Oncotarget. 2017 Apr 20;8(41):69435-69455. doi: 10.18632/oncotarget.17279. eCollection 2017 Sep 19.
|
| 317 |
PIGU overexpression adds value to TNM staging in the prognostic stratification of patients with hepatocellular carcinoma.Hum Pathol. 2019 Jan;83:90-99. doi: 10.1016/j.humpath.2018.08.013. Epub 2018 Aug 30.
|
| 318 |
MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway.Hum Cell. 2020 Jan;33(1):185-194. doi: 10.1007/s13577-019-00285-x. Epub 2019 Oct 11.
|
| 319 |
Identification of urine PLK2 as a marker of bladder tumors by proteomic analysis.World J Urol. 2010 Feb;28(1):117-22. doi: 10.1007/s00345-009-0432-y. Epub 2009 Jun 9.
|
| 320 |
Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer.Br J Cancer. 2016 Jul 26;115(3):354-63. doi: 10.1038/bjc.2016.179. Epub 2016 Jun 16.
|
| 321 |
Proteomic characterization of arsenic and cadmium exposure in bladder cells.Rapid Commun Mass Spectrom. 2020 Apr;34 Suppl 1:e8578. doi: 10.1002/rcm.8578. Epub 2020 Feb 8.
|
| 322 |
Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.Toxicol Lett. 2018 Oct 1;295:64-73. doi: 10.1016/j.toxlet.2018.05.035. Epub 2018 May 30.
|
| 323 |
Loss of PPM1A expression enhances invasion and the epithelial-to-mesenchymal transition in bladder cancer by activating the TGF-/Smad signaling pathway.Oncotarget. 2014 Jul 30;5(14):5700-11. doi: 10.18632/oncotarget.2144.
|
| 324 |
Wild-type p53-induced phosphatase 1 is a prognostic marker and therapeutic target in bladder transitional cell carcinoma.Oncol Lett. 2017 Feb;13(2):875-880. doi: 10.3892/ol.2016.5475. Epub 2016 Dec 8.
|
| 325 |
Analysis of Autoantibodies Related to Tumor Progression in Sera from Patients with High-grade Non-muscle-invasive Bladder Cancer.Anticancer Res. 2017 Dec;37(12):6705-6714. doi: 10.21873/anticanres.12129.
|
| 326 |
Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.Int J Oncol. 2017 Jul;51(1):39-48. doi: 10.3892/ijo.2017.3997. Epub 2017 May 16.
|
| 327 |
Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk.Int J Med Sci. 2012;9(6):498-505. doi: 10.7150/ijms.4799. Epub 2012 Aug 17.
|
| 328 |
Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498.Gene. 2019 Dec 15;720:144099. doi: 10.1016/j.gene.2019.144099. Epub 2019 Aug 31.
|
| 329 |
The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.J Ovarian Res. 2016 Mar 31;9:20. doi: 10.1186/s13048-016-0228-9.
|
| 330 |
Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.J Cell Physiol. 2020 Feb;235(2):1711-1722. doi: 10.1002/jcp.29090. Epub 2019 Jul 15.
|
| 331 |
CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1.Cell Death Dis. 2018 Oct 12;9(10):1046. doi: 10.1038/s41419-018-1109-5.
|
| 332 |
Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer.J Urol. 2002 Oct;168(4 Pt 1):1568-73. doi: 10.1016/S0022-5347(05)64522-3.
|
| 333 |
Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.Cancer Res. 2019 May 15;79(10):2604-2618. doi: 10.1158/0008-5472.CAN-18-3842. Epub 2019 Feb 26.
|
| 334 |
Overexpression of PTK6 predicts poor prognosis in bladder cancer patients.J Cancer. 2017 Sep 27;8(17):3464-3473. doi: 10.7150/jca.21318. eCollection 2017.
|
| 335 |
Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.World J Urol. 2016 Jun;34(6):835-46. doi: 10.1007/s00345-015-1698-x. Epub 2015 Oct 3.
|
| 336 |
Urinary retinoic acid receptor-2 gene promoter methylation and hyaluronidase activity as noninvasive tests for diagnosis of bladder cancer.Clin Biochem. 2012 Apr;45(6):402-7. doi: 10.1016/j.clinbiochem.2012.01.010. Epub 2012 Jan 18.
|
| 337 |
Downregulation of Ral GTPase-activating protein promotes tumor invasion and metastasis of bladder cancer.Oncogene. 2013 Feb 14;32(7):894-902. doi: 10.1038/onc.2012.101. Epub 2012 Mar 26.
|
| 338 |
Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.Arch Toxicol. 2008 Sep;82(9):633-9. doi: 10.1007/s00204-007-0276-4. Epub 2008 Jan 16.
|
| 339 |
Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain1 promotes bladder cancer progression.FEBS J. 2015 Jan;282(1):174-82. doi: 10.1111/febs.13116. Epub 2014 Dec 3.
|
| 340 |
Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer.Cancer. 2013 May 1;119(9):1643-51. doi: 10.1002/cncr.27871. Epub 2013 Mar 25.
|
| 341 |
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.Oncotarget. 2016 Oct 25;7(43):69159-69172. doi: 10.18632/oncotarget.12473.
|
| 342 |
Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer.Pathol Oncol Res. 2020 Jan;26(1):253-261. doi: 10.1007/s12253-018-0447-z. Epub 2018 Jul 17.
|
| 343 |
miR-204 Negatively Regulates Cell Growth And Metastasis By Targeting ROBO4 In Human Bladder Cancer.Onco Targets Ther. 2019 Oct 16;12:8515-8524. doi: 10.2147/OTT.S205023. eCollection 2019.
|
| 344 |
MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1.Mol Med Rep. 2016 May;13(5):4379-85. doi: 10.3892/mmr.2016.5055. Epub 2016 Mar 28.
|
| 345 |
Targeted regulation by ROCK2 on bladder carcinoma via Wnt signaling under hypoxia.Cancer Biomark. 2019;24(1):109-116. doi: 10.3233/CBM-181949.
|
| 346 |
Decreased c-Myc mRNA Stability via the MicroRNA 141-3p/AUF1 Axis Is Crucial for p63 Inhibition of Cyclin D1 Gene Transcription and Bladder Cancer Cell Tumorigenicity.Mol Cell Biol. 2018 Oct 15;38(21):e00273-18. doi: 10.1128/MCB.00273-18. Print 2018 Nov 1.
|
| 347 |
Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.EBioMedicine. 2018 Sep;35:198-203. doi: 10.1016/j.ebiom.2018.06.011. Epub 2018 Jun 22.
|
| 348 |
Ribonucleotide reductase M2 subunit expression and prognostic value in nasopharyngeal carcinoma.Mol Med Rep. 2015 Jul;12(1):401-9. doi: 10.3892/mmr.2015.3360. Epub 2015 Feb 16.
|
| 349 |
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation.Elife. 2017 Nov 16;6:e30862. doi: 10.7554/eLife.30862.
|
| 350 |
Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).Adv Ther. 2018 Nov;35(11):2054-2068. doi: 10.1007/s12325-018-0789-7. Epub 2018 Sep 19.
|
| 351 |
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.Sci Rep. 2017 Oct 4;7(1):12682. doi: 10.1038/s41598-017-12892-5.
|
| 352 |
Sphingosine 1 phosphate receptor-1 (S1P1) promotes tumor-associated regulatory T cell expansion: leading to poor survival in bladder cancer.Cell Death Dis. 2019 Jan 18;10(2):50. doi: 10.1038/s41419-018-1298-y.
|
| 353 |
SATB1 and bladder cancer: Is there a functional link?.Urol Oncol. 2018 Mar;36(3):93.e13-93.e21. doi: 10.1016/j.urolonc.2017.10.004. Epub 2017 Oct 25.
|
| 354 |
Inhibition of stearoyl CoA desaturase-1 activity suppresses tumour progression and improves prognosis in human bladder cancer.J Cell Mol Med. 2019 Mar;23(3):2064-2076. doi: 10.1111/jcmm.14114. Epub 2018 Dec 27.
|
| 355 |
Clinical implications in the shift of syndecan-1 expression from the cell membrane to the cytoplasm in bladder cancer.BMC Cancer. 2014 Feb 13;14:86. doi: 10.1186/1471-2407-14-86.
|
| 356 |
5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.Cancer Biother Radiopharm. 2013 May;28(4):343-50. doi: 10.1089/cbr.2012.1303. Epub 2013 Apr 9.
|
| 357 |
Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.Cell Death Dis. 2017 Feb 2;8(2):e2581. doi: 10.1038/cddis.2017.13.
|
| 358 |
Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.Br J Cancer. 1999 Oct;81(3):537-41. doi: 10.1038/sj.bjc.6690727.
|
| 359 |
Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11. Clin Cancer Res. 2014 Apr 1;20(7):1990-2000.
|
| 360 |
SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.Cancer Invest. 2014 Jul;32(6):256-61. doi: 10.3109/07357907.2014.907421. Epub 2014 Apr 24.
|
| 361 |
Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.Tumour Biol. 2016 Jun;37(6):7371-81. doi: 10.1007/s13277-015-4410-2. Epub 2015 Dec 16.
|
| 362 |
Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.Cancer Res. 2005 Dec 15;65(24):11581-7. doi: 10.1158/0008-5472.CAN-05-1622.
|
| 363 |
Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer.J Urol. 2006 May;175(5):1915-20. doi: 10.1016/S0022-5347(05)00919-5.
|
| 364 |
Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa-miR-132-3p/Sox5 signalling pathway.Cell Prolif. 2019 Jul;52(4):e12614. doi: 10.1111/cpr.12614. Epub 2019 Apr 14.
|
| 365 |
Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.Int J Cancer. 2014 Jul 15;135(2):335-47. doi: 10.1002/ijc.28693. Epub 2014 Jan 13.
|
| 366 |
HMGB3 promotes growth and migration in colorectal cancer by regulating WNT/-catenin pathway.PLoS One. 2017 Jul 5;12(7):e0179741. doi: 10.1371/journal.pone.0179741. eCollection 2017.
|
| 367 |
Pattern of somatostatin receptors expression in normal and bladder cancer tissue samples.Anticancer Res. 2014 Jun;34(6):2937-42.
|
| 368 |
ASC-J9 increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-B survival signals.J Exp Clin Cancer Res. 2019 Jun 24;38(1):275. doi: 10.1186/s13046-019-1258-0.
|
| 369 |
The KMT1A-GATA3-STAT3 Circuit Is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells.Clin Cancer Res. 2017 Nov 1;23(21):6673-6685. doi: 10.1158/1078-0432.CCR-17-0882. Epub 2017 Aug 1.
|
| 370 |
Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.Int J Oncol. 2018 Aug;53(2):515-526. doi: 10.3892/ijo.2018.4423. Epub 2018 May 30.
|
| 371 |
CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis.Medicine (Baltimore). 2019 Jan;98(2):e13847. doi: 10.1097/MD.0000000000013847.
|
| 372 |
MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle.J Cell Physiol. 2019 Apr;234(4):4910-4923. doi: 10.1002/jcp.27288. Epub 2018 Oct 14.
|
| 373 |
TBK1 Promote Bladder Cancer Cell Proliferation and Migration via Akt Signaling.J Cancer. 2017 Jul 3;8(10):1892-1899. doi: 10.7150/jca.17638. eCollection 2017.
|
| 374 |
Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study.Carcinogenesis. 2005 Oct;26(10):1741-7. doi: 10.1093/carcin/bgi126. Epub 2005 May 19.
|
| 375 |
Dual role of TGFBR3 in bladder cancer.Oncol Rep. 2013 Sep;30(3):1301-8. doi: 10.3892/or.2013.2599. Epub 2013 Jul 8.
|
| 376 |
DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.Int J Cancer. 2018 Jul 15;143(2):289-297. doi: 10.1002/ijc.31318. Epub 2018 Mar 1.
|
| 377 |
Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.Mol Med Rep. 2018 Sep;18(3):3403-3410. doi: 10.3892/mmr.2018.9306. Epub 2018 Jul 23.
|
| 378 |
Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience.Clin Chem Lab Med. 2007;45(7):862-6. doi: 10.1515/CCLM.2007.133.
|
| 379 |
Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-B/IKK pathway-induced apoptosis.PLoS One. 2013;8(1):e50175. doi: 10.1371/journal.pone.0050175. Epub 2013 Jan 24.
|
| 380 |
DNA topoisomerase II and RAD21 cohesin complex component are predicted as potential therapeutic targets in bladder cancer.Oncol Lett. 2019 Jul;18(1):518-528. doi: 10.3892/ol.2019.10365. Epub 2019 May 17.
|
| 381 |
Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.J Cell Physiol. 2019 Aug;234(10):19073-19087. doi: 10.1002/jcp.28546. Epub 2019 Mar 29.
|
| 382 |
Clinical significance and biological roles of TRIM24 in human bladder carcinoma.Tumour Biol. 2015 Sep;36(9):6849-55. doi: 10.1007/s13277-015-3393-3. Epub 2015 Apr 7.
|
| 383 |
TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.Mol Carcinog. 2018 Dec;57(12):1792-1802. doi: 10.1002/mc.22897. Epub 2018 Sep 20.
|
| 384 |
TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells.Cancer Biother Radiopharm. 2015 Mar;30(2):87-93. doi: 10.1089/cbr.2014.1697.
|
| 385 |
TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.Oncol Rep. 2017 Oct;38(4):1967-1976. doi: 10.3892/or.2017.5883. Epub 2017 Aug 7.
|
| 386 |
Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder.Tumour Biol. 2014 Nov;35(11):11499-504. doi: 10.1007/s13277-014-2480-1. Epub 2014 Aug 16.
|
| 387 |
TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion, migration and invasion.PLoS One. 2013 May 31;8(5):e64885. doi: 10.1371/journal.pone.0064885. Print 2013.
|
| 388 |
Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity.Carcinogenesis. 2001 May;22(5):813-5. doi: 10.1093/carcin/22.5.813.
|
| 389 |
Expression of the fluoropyrimidine-metabolizing enzymes in bladder cancers as measured by the Danenberg tumor profile.Oncol Res. 2009;18(4):153-62. doi: 10.3727/096504009790217371.
|
| 390 |
Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.Cancer Med. 2013 Aug;2(4):488-95. doi: 10.1002/cam4.95. Epub 2013 Jun 10.
|
| 391 |
Evaluation of the diagnostic accuracy of UBC() Rapid in bladder cancer: a Swedish multicentre study.Scand J Urol. 2017 Aug;51(4):293-300. doi: 10.1080/21681805.2017.1313309. Epub 2017 Apr 19.
|
| 392 |
Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.Oncol Res. 2016;24(5):361-369. doi: 10.3727/096504016X14685034103310.
|
| 393 |
Identification and validation of a novel autophagy gene expression signature for human bladder cancer patients.Tumour Biol. 2017 Apr;39(4):1010428317698360. doi: 10.1177/1010428317698360.
|
| 394 |
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.J Exp Clin Cancer Res. 2014 Jun 3;33(1):48. doi: 10.1186/1756-9966-33-48.
|
| 395 |
Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.Cancer Med. 2020 Jan;9(2):700-710. doi: 10.1002/cam4.2650. Epub 2019 Nov 23.
|
| 396 |
Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.Oncol Rep. 2009 Jun;21(6):1495-504. doi: 10.3892/or_00000380.
|
| 397 |
B7-Homolog 4 Promotes Epithelial-Mesenchymal Transition and Invasion of Bladder Cancer Cells via Activation of Nuclear Factor-B.Oncol Res. 2018 Sep 14;26(8):1267-1274. doi: 10.3727/096504018X15172227703244. Epub 2018 Feb 1.
|
| 398 |
Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation.Sci Rep. 2015 Feb 6;5:8293. doi: 10.1038/srep08293.
|
| 399 |
MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/-Catenin Signaling.Cell Physiol Biochem. 2018;48(2):815-826. doi: 10.1159/000491911. Epub 2018 Jul 20.
|
| 400 |
Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan.Anticancer Res. 2009 Apr;29(4):1275-9.
|
| 401 |
DEP domain containing 1 suppresses apoptosis via inhibition of A20 expression, which activates the nuclear factor B signaling pathway in HepG2 cells.Oncol Lett. 2018 Jul;16(1):949-955. doi: 10.3892/ol.2018.8770. Epub 2018 May 22.
|
| 402 |
Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer.BMC Syst Biol. 2018 Dec 14;12(Suppl 7):118. doi: 10.1186/s12918-018-0634-2.
|
| 403 |
Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.Eur Urol. 2005 Feb;47(2):250-6. doi: 10.1016/j.eururo.2004.09.009.
|
| 404 |
CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status.Clin Cancer Res. 2019 Jan 1;25(1):390-402. doi: 10.1158/1078-0432.CCR-18-0685. Epub 2018 Sep 21.
|
| 405 |
Pesticides, gene polymorphisms, and bladder cancer among Egyptian agricultural workers.Arch Environ Occup Health. 2015;70(1):19-26. doi: 10.1080/19338244.2013.853646.
|
| 406 |
CYP1A2-163C/A (rs762551) polymorphism and bladder cancer risk: a case-control study.Genet Mol Res. 2016 Apr 26;15(2). doi: 10.4238/gmr.15026298.
|
| 407 |
Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population.World J Gastroenterol. 2004 Jul 1;10(13):1961-3. doi: 10.3748/wjg.v10.i13.463.
|
| 408 |
XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion.Oncogenesis. 2019 Dec 6;8(12):71. doi: 10.1038/s41389-019-0181-8.
|
| 409 |
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL.Oncogene. 2012 Mar 22;31(12):1493-503. doi: 10.1038/onc.2011.336. Epub 2011 Aug 8.
|
| 410 |
Common Polymorphisms in GSTA1, GSTM1 and GSTT1 Are Associated with Susceptibility to Urinary Bladder Cancer in Individuals from Balkan Endemic Nephropathy Areas of Serbia.Tohoku J Exp Med. 2016 Sep;240(1):25-30. doi: 10.1620/tjem.240.25.
|
| 411 |
Integrin-linked kinase regulates cadherin switch in bladder cancer.Tumour Biol. 2016 Nov;37(11):15185-15191. doi: 10.1007/s13277-016-5354-x. Epub 2016 Sep 28.
|
| 412 |
KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway.Cancer Manag Res. 2019 Feb 26;11:1857-1868. doi: 10.2147/CMAR.S191681. eCollection 2019.
|
| 413 |
Attenuated NER expressions of XPF and XPC associated with smoking are involved in the recurrence of bladder cancer.PLoS One. 2014 Dec 23;9(12):e115224. doi: 10.1371/journal.pone.0115224. eCollection 2014.
|
| 414 |
A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-Like Properties and Invasion in Human Bladder Cancer.Cancers (Basel). 2019 Mar 12;11(3):349. doi: 10.3390/cancers11030349.
|
| 415 |
Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals.Cancer Invest. 2018;36(8):407-414. doi: 10.1080/07357907.2018.1514504. Epub 2018 Oct 2.
|
| 416 |
Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Gurin induce antitumor immunity in a syngeneic murine bladder cancer model.PLoS One. 2019 Jan 4;14(1):e0209196. doi: 10.1371/journal.pone.0209196. eCollection 2019.
|
| 417 |
Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.PLoS One. 2012;7(11):e51056. doi: 10.1371/journal.pone.0051056. Epub 2012 Nov 30.
|
| 418 |
Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line.Asian Pac J Cancer Prev. 2013;14(6):3773-8. doi: 10.7314/apjcp.2013.14.6.3773.
|
| 419 |
Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.Am J Cancer Res. 2017 Nov 1;7(11):2209-2219. eCollection 2017.
|
| 420 |
Expression of RFC/SLC19A1 is associated with tumor type in bladder cancer patients.PLoS One. 2011;6(7):e21820. doi: 10.1371/journal.pone.0021820. Epub 2011 Jul 8.
|
| 421 |
Overexpression of SET and MYND Domain-Containing Protein 2 (SMYD2) Is Associated with Tumor Progression and Poor Prognosis in Patients with Papillary Thyroid Carcinoma.Med Sci Monit. 2018 Oct 15;24:7357-7365. doi: 10.12659/MSM.910168.
|
| 422 |
miR-203 Suppresses Bladder Cancer Cell Growth and Targets Twist1.Oncol Res. 2018 Sep 14;26(8):1155-1165. doi: 10.3727/096504017X15041934685237. Epub 2017 Sep 6.
|
| 423 |
CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling.Biosci Rep. 2019 Dec 20;39(12):BSR20192779. doi: 10.1042/BSR20192779.
|
| 424 |
NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Gurin therapy for bladder cancer.Eur Urol. 2011 Mar;59(3):430-7. doi: 10.1016/j.eururo.2010.11.031. Epub 2010 Dec 1.
|
| 425 |
Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.Urol Oncol. 2014 Jan;32(1):39.e29-36. doi: 10.1016/j.urolonc.2013.04.005. Epub 2013 Jun 18.
|
| 426 |
Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device.Cell Cycle. 2015;14(19):3058-65. doi: 10.1080/15384101.2015.1053666. Epub 2015 Jun 30.
|
| 427 |
A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis.Tumour Biol. 2015 Jan;36(1):383-91. doi: 10.1007/s13277-014-2617-2. Epub 2014 Sep 30.
|
| 428 |
MiR-411 suppresses the development of bladder cancer by regulating ZnT1.Onco Targets Ther. 2018 Dec 4;11:8695-8704. doi: 10.2147/OTT.S173750. eCollection 2018.
|
| 429 |
A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment.Int J Hyperthermia. 2013 Sep;29(6):528-38. doi: 10.3109/02656736.2013.790563. Epub 2013 Jul 23.
|
| 430 |
Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk.Br J Cancer. 2013 Jun 11;108(11):2372-80. doi: 10.1038/bjc.2013.190. Epub 2013 Apr 30.
|
| 431 |
Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.Tumour Biol. 2015 Sep;36(10):7431-7. doi: 10.1007/s13277-015-3459-2. Epub 2015 Apr 23.
|
| 432 |
SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. Hum Genet. 2012 Mar;131(3):453-61. doi: 10.1007/s00439-011-1090-x. Epub 2011 Sep 25.
|
| 433 |
Vasitis nodosa and related lesions: a modern immunohistochemical staining profile with special emphasis on novel diagnostic dilemmas.Hum Pathol. 2018 Mar;73:164-170. doi: 10.1016/j.humpath.2017.12.001. Epub 2017 Dec 11.
|
| 434 |
Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins.Adv Clin Exp Med. 2017 Oct;26(7):1069-1075. doi: 10.17219/acem/63156.
|
| 435 |
CYP27A1 inhibits bladder cancer cells proliferation by regulating cholesterol homeostasis.Cell Cycle. 2019 Jan;18(1):34-45. doi: 10.1080/15384101.2018.1558868. Epub 2018 Dec 30.
|
| 436 |
Variation in genes encoding the neuroactive steroid synthetic enzymes 5-reductase type 1 and 3-reductase type 2 is associated with alcohol dependence.Alcohol Clin Exp Res. 2011 May;35(5):946-52. doi: 10.1111/j.1530-0277.2010.01425.x. Epub 2011 Feb 15.
|
| 437 |
Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice.Int J Mol Sci. 2019 Oct 9;20(20):4983. doi: 10.3390/ijms20204983.
|
| 438 |
Uridine Cytidine Kinase 2 as a Potential Biomarker for Treatment with RX-3117 in Pancreatic Cancer.Anticancer Res. 2019 Jul;39(7):3609-3614. doi: 10.21873/anticanres.13508.
|
| 439 |
Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.J Cancer Res Clin Oncol. 2018 Mar;144(3):469-482. doi: 10.1007/s00432-017-2567-3. Epub 2018 Jan 5.
|
| 440 |
Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):413-421. doi: 10.1016/j.bbalip.2018.06.005. Epub 2018 Jun 5.
|
| 441 |
Alcohol dehydrogenase type 3 (ADH3) and the risk of bladder cancer.Eur Urol. 2001 Nov;40(5):509-14. doi: 10.1159/000049827.
|
| 442 |
The Diagnostic Significance of Serum Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in Urinary Bladder Cancer Patients.Anticancer Res. 2017 Jul;37(7):3537-3541. doi: 10.21873/anticanres.11722.
|
| 443 |
Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.Int J Clin Oncol. 2013 Feb;18(1):177-82. doi: 10.1007/s10147-011-0363-7. Epub 2011 Dec 27.
|
| 444 |
Aldo-keto reductase 1C1 induced by interleukin-1 mediates the invasive potential and drug resistance of metastatic bladder cancer cells.Sci Rep. 2016 Oct 4;6:34625. doi: 10.1038/srep34625.
|
| 445 |
A risk score staging system based on the expression of seven genes predicts the outcome of bladder cancer.Oncol Lett. 2018 Aug;16(2):2091-2096. doi: 10.3892/ol.2018.8904. Epub 2018 Jun 5.
|
| 446 |
Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer.Toxicol Sci. 2018 Jul 1;164(1):328-338. doi: 10.1093/toxsci/kfy087.
|
| 447 |
Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation.Drug Metab Pharmacokinet. 2018 Feb;33(1):82-89. doi: 10.1016/j.dmpk.2017.11.004. Epub 2017 Nov 22.
|
| 448 |
LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression.Biosci Rep. 2019 Apr 12;39(4):BSR20182372. doi: 10.1042/BSR20182372. Print 2019 Apr 30.
|
| 449 |
Genotoxicity of disinfection byproducts and disinfected waters: A review of recent literature.Mutat Res Genet Toxicol Environ Mutagen. 2018 Jul;831:1-12. doi: 10.1016/j.mrgentox.2018.04.005. Epub 2018 Apr 24.
|
| 450 |
HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.PLoS One. 2012;7(12):e51301. doi: 10.1371/journal.pone.0051301. Epub 2012 Dec 19.
|
| 451 |
MicroRNA-940 Targets INPP4A or GSK3 and Activates the Wnt/-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.Oncol Res. 2018 Jan 19;26(1):145-155. doi: 10.3727/096504017X14902261600566. Epub 2017 Mar 23.
|
| 452 |
High expression of enhancer RNA MARC1 or its activation by DHT is associated with the malignant behavior in bladder cancer.Exp Cell Res. 2018 Sep 15;370(2):303-311. doi: 10.1016/j.yexcr.2018.06.032. Epub 2018 Jun 28.
|
| 453 |
Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy.Sci Rep. 2018 Jan 15;8(1):794. doi: 10.1038/s41598-018-19146-y.
|
| 454 |
Clinical performance and utility of a NNMT-based urine test for bladder cancer.Int J Biol Markers. 2018 Jan;33(1):94-101. doi: 10.5301/ijbm.5000311.
|
| 455 |
Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.Cell Oncol (Dordr). 2018 Oct;41(5):555-568. doi: 10.1007/s13402-018-0393-5. Epub 2018 Jun 28.
|
| 456 |
Exploring the role of paraoxonase-2 in bladder cancer: analyses performed on tissue samples, urines and cell cultures.Oncotarget. 2017 Apr 25;8(17):28785-28795. doi: 10.18632/oncotarget.15674.
|
| 457 |
Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.Int J Urol. 2007 Sep;14(9):795-9. doi: 10.1111/j.1442-2042.2007.01840.x.
|
| 458 |
Occupational exposures and genetic susceptibility to urinary tract cancers: a systematic review and meta-analysis.Eur J Cancer Prev. 2018 Sep;27(5):468-476. doi: 10.1097/CEJ.0000000000000364.
|
| 459 |
Genome-wide association study identifies multiple loci associated with bladder cancer risk.Hum Mol Genet. 2014 Mar 1;23(5):1387-98. doi: 10.1093/hmg/ddt519. Epub 2013 Oct 24.
|
| 460 |
Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.J Biochem. 2010 Mar;147(3):353-60. doi: 10.1093/jb/mvp169. Epub 2009 Oct 29.
|
| 461 |
The association between UGT1A7 polymorphism and cancer risk: a meta-analysis.Cancer Epidemiol. 2012 Aug;36(4):e201-6. doi: 10.1016/j.canep.2012.02.004. Epub 2012 Mar 7.
|
| 462 |
Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population.Environ Health Prev Med. 2013 Mar;18(2):136-42. doi: 10.1007/s12199-012-0302-x. Epub 2012 Sep 9.
|
| 463 |
Possible relationship between the risk of Japanese bladder cancer cases and the CYP4B1 genotype.Jpn J Clin Oncol. 2008 Sep;38(9):634-40. doi: 10.1093/jjco/hyn081. Epub 2008 Aug 19.
|
| 464 |
The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers.J Clin Lab Anal. 2020 Jan;34(1):e23049. doi: 10.1002/jcla.23049. Epub 2019 Sep 25.
|
| 465 |
Whole-genome sequencing identifies ADGRG6 enhancer mutations and FRS2 duplications as angiogenesis-related drivers in bladder cancer.Nat Commun. 2019 Feb 12;10(1):720. doi: 10.1038/s41467-019-08576-5.
|
| 466 |
The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-B/MYC signaling network.Oncogene. 2019 May;38(19):3667-3680. doi: 10.1038/s41388-019-0683-z. Epub 2019 Jan 18.
|
| 467 |
Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion.Clin Exp Med. 2019 Nov;19(4):525-534. doi: 10.1007/s10238-019-00576-5. Epub 2019 Aug 28.
|
| 468 |
ARPC4 promotes bladder cancer cell invasion and is associated with lymph node metastasis.J Cell Biochem. 2020 Jan;121(1):231-243. doi: 10.1002/jcb.29136. Epub 2019 Jun 12.
|
| 469 |
Oxidative stress and LINE-1 reactivation in bladder cancer are epigenetically linked through active chromatin formation.Free Radic Biol Med. 2019 Apr;134:419-428. doi: 10.1016/j.freeradbiomed.2019.01.031. Epub 2019 Jan 29.
|
| 470 |
Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation.Investig Clin Urol. 2019 Sep;60(5):396-404. doi: 10.4111/icu.2019.60.5.396. Epub 2019 Jul 17.
|
| 471 |
Dynamic m(6)A mRNA methylation reveals the role of METTL3-m(6)A-CDCP1 signaling axis in chemical carcinogenesis.Oncogene. 2019 Jun;38(24):4755-4772. doi: 10.1038/s41388-019-0755-0. Epub 2019 Feb 22.
|
| 472 |
Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.J Comput Biol. 2020 Jun;27(6):987-998. doi: 10.1089/cmb.2019.0237. Epub 2019 Sep 23.
|
| 473 |
Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.Med Sci Monit. 2019 Apr 25;25:3041-3060. doi: 10.12659/MSM.915487.
|
| 474 |
Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer.Hum Pathol. 2019 Mar;85:152-161. doi: 10.1016/j.humpath.2018.11.007. Epub 2018 Nov 17.
|
| 475 |
Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer.Onco Targets Ther. 2019 Feb 20;12:1423-1432. doi: 10.2147/OTT.S191321. eCollection 2019.
|
| 476 |
The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.BMC Cancer. 2019 Mar 12;19(1):225. doi: 10.1186/s12885-019-5423-9.
|
| 477 |
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer.Sci Rep. 2019 Apr 5;9(1):5740. doi: 10.1038/s41598-018-36456-3.
|
| 478 |
NFB2 p52 stabilizes rhogdi mRNA by inhibiting AUF1 protein degradation via a miR-145/Sp1/USP8-dependent axis.Mol Carcinog. 2019 May;58(5):777-793. doi: 10.1002/mc.22970. Epub 2019 Jan 29.
|
| 479 |
Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.J Cell Biochem. 2019 Apr;120(4):6471-6481. doi: 10.1002/jcb.27938. Epub 2018 Nov 11.
|
| 480 |
Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer.Am J Clin Pathol. 2020 Jan 2;153(2):274-284. doi: 10.1093/ajcp/aqz165.
|
| 481 |
Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis.Front Genet. 2019 Mar 29;10:280. doi: 10.3389/fgene.2019.00280. eCollection 2019.
|
| 482 |
ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis.Biochem Biophys Res Commun. 2019 Nov 5;519(2):246-252. doi: 10.1016/j.bbrc.2019.08.129. Epub 2019 Sep 5.
|
| 483 |
A six-gene prognostic model predicts overall survival in bladder cancer patients.Cancer Cell Int. 2019 Sep 5;19:229. doi: 10.1186/s12935-019-0950-7. eCollection 2019.
|
| 484 |
Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression.Front Med (Lausanne). 2017 Mar 17;4:30. doi: 10.3389/fmed.2017.00030. eCollection 2017.
|
| 485 |
Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.Cancer Lett. 2019 May 1;449:31-44. doi: 10.1016/j.canlet.2019.01.041. Epub 2019 Feb 10.
|
| 486 |
Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer.Transl Oncol. 2019 Nov;12(11):1416-1424. doi: 10.1016/j.tranon.2019.07.012. Epub 2019 Aug 8.
|
| 487 |
Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.Cancer Lett. 2020 Mar 31;473:118-129. doi: 10.1016/j.canlet.2019.12.018. Epub 2019 Dec 13.
|
| 488 |
High NRBP1 expression promotes proliferation and correlates with poor prognosis in bladder cancer.J Cancer. 2019 Jul 10;10(18):4270-4277. doi: 10.7150/jca.32656. eCollection 2019.
|
| 489 |
LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.J Exp Clin Cancer Res. 2019 Apr 2;38(1):143. doi: 10.1186/s13046-019-1149-4.
|
| 490 |
PLC promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathwaymediated glycolysis.Oncol Rep. 2019 May;41(5):2844-2854. doi: 10.3892/or.2019.7056. Epub 2019 Mar 13.
|
| 491 |
NNT-AS1 enhances bladder cancer cell growth by targeting miR-1301-3p/PODXL axis and activating Wnt pathway.Neurourol Urodyn. 2020 Feb;39(2):547-557. doi: 10.1002/nau.24238. Epub 2019 Nov 29.
|
| 492 |
Prothymosin- enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.Cancer Sci. 2019 Apr;110(4):1208-1219. doi: 10.1111/cas.13963. Epub 2019 Mar 5.
|
| 493 |
RAB14 activates MAPK signaling to promote bladder tumorigenesis.Carcinogenesis. 2019 Nov 25;40(11):1341-1351. doi: 10.1093/carcin/bgz039.
|
| 494 |
Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.J Pharmacol Exp Ther. 2020 Mar;372(3):237-247. doi: 10.1124/jpet.119.262949. Epub 2019 Dec 16.
|
| 495 |
RAB38 promotes bladder cancer growth by promoting cell proliferation and motility.World J Urol. 2019 Sep;37(9):1889-1897. doi: 10.1007/s00345-018-2596-9. Epub 2018 Dec 10.
|
| 496 |
Overexpression of ribonuclease inhibitor induces autophagy in human colorectal cancer cells via the Akt/mTOR/ULK1 pathway.Mol Med Rep. 2019 May;19(5):3519-3526. doi: 10.3892/mmr.2019.10030. Epub 2019 Mar 14.
|
| 497 |
Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis.J Cell Physiol. 2020 Apr;235(4):3768-3775. doi: 10.1002/jcp.29271. Epub 2019 Oct 14.
|
| 498 |
MiR-506 inhibits cell proliferation, invasion, migration and epithelial-to-mesenchymal transition through targeting RWDD4 in human bladder cancer.Oncol Lett. 2019 Jan;17(1):73-78. doi: 10.3892/ol.2018.9594. Epub 2018 Oct 18.
|
| 499 |
Serine/threonine kinase 32C is overexpressed in bladder cancer and contributes to tumor progression.Cancer Biol Ther. 2019;20(3):307-320. doi: 10.1080/15384047.2018.1529098. Epub 2018 Oct 25.
|
| 500 |
Increased expression levels of Syntaxin 1A and Synaptobrevin 2/Vesicle-Associated Membrane Protein-2 are associated with the progression of bladder cancer.Genet Mol Biol. 2019 Jan-Mar;42(1):40-47. doi: 10.1590/1678-4685-GMB-2017-0339. Epub 2019 Jan 21.
|
| 501 |
Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.Cell Prolif. 2019 Mar;52(2):e12560. doi: 10.1111/cpr.12560. Epub 2018 Dec 4.
|
| 502 |
Detection of LOH of the RB1 gene in bladder cancers by PCR-RFLP.Urol Int. 2002;68(3):189-92. doi: 10.1159/000048448.
|
| 503 |
Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance.Oncotarget. 2018 Jan 13;9(17):13231-13243. doi: 10.18632/oncotarget.24229. eCollection 2018 Mar 2.
|
| 504 |
Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder.Int J Mol Sci. 2018 May 31;19(6):1622. doi: 10.3390/ijms19061622.
|
| 505 |
Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.J Exp Clin Cancer Res. 2019 Jul 8;38(1):292. doi: 10.1186/s13046-019-1286-9.
|
| 506 |
A novel cellular senescence gene, SENEX, is involved in peripheral regulatory T cells accumulation in aged urinary bladder cancer.PLoS One. 2014 Feb 5;9(2):e87774. doi: 10.1371/journal.pone.0087774. eCollection 2014.
|
| 507 |
III-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer.Hum Pathol. 2017 Mar;61:210-220. doi: 10.1016/j.humpath.2016.11.005. Epub 2016 Dec 24.
|
| 508 |
Norcantharidin inhibits the DDR of bladder cancer stem-like cells through cdc6 degradation.Onco Targets Ther. 2019 Jun 7;12:4403-4413. doi: 10.2147/OTT.S209907. eCollection 2019.
|
| 509 |
Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.J Hum Genet. 2018 May;63(5):657-668. doi: 10.1038/s10038-018-0437-8. Epub 2018 Mar 14.
|
| 510 |
Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.Biomed Res Int. 2019 Nov 16;2019:3917982. doi: 10.1155/2019/3917982. eCollection 2019.
|
| 511 |
Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer.Medicine (Baltimore). 2018 Apr;97(15):e0353. doi: 10.1097/MD.0000000000010353.
|
| 512 |
SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.Trials. 2018 Apr 3;19(1):216. doi: 10.1186/s13063-018-2586-7.
|
| 513 |
CIZ1 knockdown suppresses the proliferation of bladder cancer cells by inducing apoptosis.Gene. 2019 Nov 30;719:143946. doi: 10.1016/j.gene.2019.143946. Epub 2019 Jun 25.
|
| 514 |
Diagnostic and prognostic role of urinary collagens in primary human bladder cancer.Cancer Sci. 2017 Nov;108(11):2221-2228. doi: 10.1111/cas.13384. Epub 2017 Sep 15.
|
| 515 |
A DDX31/Mutant-p53/EGFR Axis Promotes Multistep Progression of Muscle-Invasive Bladder Cancer.Cancer Res. 2018 May 1;78(9):2233-2247. doi: 10.1158/0008-5472.CAN-17-2528. Epub 2018 Feb 13.
|
| 516 |
METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.Mol Cancer. 2019 Jun 22;18(1):110. doi: 10.1186/s12943-019-1036-9.
|
| 517 |
Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA.Cancer Cell Int. 2019 May 30;19:149. doi: 10.1186/s12935-019-0874-2. eCollection 2019.
|
| 518 |
eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.Cell Oncol (Dordr). 2014 Aug;37(4):253-67. doi: 10.1007/s13402-014-0181-9. Epub 2014 Jul 29.
|
| 519 |
E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.Cancer Biomark. 2019;25(2):223-232. doi: 10.3233/CBM-190013.
|
| 520 |
The esterase D polymorphism in patients with diabetes or carcinoma of the bladder and a matched sample of non-donor controls.Ann Hum Biol. 1978 May;5(3):281-4. doi: 10.1080/03014467800002901.
|
| 521 |
Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer.Mol Ther Nucleic Acids. 2019 Dec 6;18:787-800. doi: 10.1016/j.omtn.2019.09.023. Epub 2019 Oct 1.
|
| 522 |
Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis.Mol Cancer. 2019 May 17;18(1):95. doi: 10.1186/s12943-019-1025-z.
|
| 523 |
The link between FOXJ1 expression level in bladder carcinoma and tumor recurrence.Oncol Lett. 2018 Feb;15(2):1483-1486. doi: 10.3892/ol.2017.7504. Epub 2017 Nov 29.
|
| 524 |
GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis.Oncotarget. 2018 Mar 23;9(22):15847-15859. doi: 10.18632/oncotarget.24627. eCollection 2018 Mar 23.
|
| 525 |
The Expression and Prognostic Impact of Immune Cytolytic Activity-Related Markers in Human Malignancies: A Comprehensive Meta-analysis.Front Oncol. 2018 Feb 21;8:27. doi: 10.3389/fonc.2018.00027. eCollection 2018.
|
| 526 |
Homeobox A10 promotes the proliferation and invasion of bladder cancer cells via regulation of matrix metalloproteinase-3.Oncol Lett. 2019 Jul;18(1):49-56. doi: 10.3892/ol.2019.10312. Epub 2019 May 3.
|
| 527 |
HOXB2 is a Putative Tumour Promotor in Human Bladder Cancer.Anticancer Res. 2019 Dec;39(12):6915-6921. doi: 10.21873/anticanres.13912.
|
| 528 |
HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo.Int J Med Sci. 2019 May 7;16(5):654-659. doi: 10.7150/ijms.31288. eCollection 2019.
|
| 529 |
The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.Cell Death Dis. 2019 Jun 4;10(6):437. doi: 10.1038/s41419-019-1669-z.
|
| 530 |
Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.Urol Oncol. 2018 Jun;36(6):311.e1-311.e13. doi: 10.1016/j.urolonc.2018.03.001. Epub 2018 Mar 27.
|
| 531 |
Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells invitro and invivo.FEBS Open Bio. 2021 May;11(5):1487-1496. doi: 10.1002/2211-5463.12768. Epub 2021 May 2.
|
| 532 |
Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3 signaling.Cancer Sci. 2019 Sep;110(9):2822-2833. doi: 10.1111/cas.14126. Epub 2019 Jul 23.
|
| 533 |
CircPTPRA acts as a tumor suppressor in bladder cancer by sponging miR-636 and upregulating KLF9.Aging (Albany NY). 2019 Dec 10;11(23):11314-11328. doi: 10.18632/aging.102530. Epub 2019 Dec 10.
|
| 534 |
Enhanced metastatic potential in the MB49 urothelial carcinoma model.Sci Rep. 2019 May 15;9(1):7425. doi: 10.1038/s41598-019-43641-5.
|
| 535 |
Adaptation to Extreme Environments in an Admixed Human Population from the Atacama Desert.Genome Biol Evol. 2019 Sep 1;11(9):2468-2479. doi: 10.1093/gbe/evz172.
|
| 536 |
LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.Biosci Rep. 2019 Jul 30;39(7):BSR20182270. doi: 10.1042/BSR20182270. Print 2019 Jul 31.
|
| 537 |
ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653.Aging (Albany NY). 2019 Dec 10;11(23):11202-11223. doi: 10.18632/aging.102525. Epub 2019 Dec 10.
|
| 538 |
MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway.Onco Targets Ther. 2019 May 1;12:3285-3294. doi: 10.2147/OTT.S199667. eCollection 2019.
|
| 539 |
Circ_0006332 promotes growth and progression of bladder cancer by modulating MYBL2 expression via miR-143.Aging (Albany NY). 2019 Nov 22;11(22):10626-10643. doi: 10.18632/aging.102481. Epub 2019 Nov 22.
|
| 540 |
miR?2?p enhances multichemoresistance by targeting NET1 in bladder cancer cells.Oncol Rep. 2018 Jun;39(6):2731-2740. doi: 10.3892/or.2018.6355. Epub 2018 Apr 4.
|
| 541 |
A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging.Nat Commun. 2019 Oct 24;10(1):4861. doi: 10.1038/s41467-019-12848-5.
|
| 542 |
Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells.Biosci Biotechnol Biochem. 2019 Dec;83(12):2265-2271. doi: 10.1080/09168451.2019.1648207. Epub 2019 Jul 31.
|
| 543 |
NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.Theranostics. 2019 Sep 23;9(24):7156-7167. doi: 10.7150/thno.36030. eCollection 2019.
|
| 544 |
Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.Pathol Oncol Res. 2020 Apr;26(2):1279-1285. doi: 10.1007/s12253-019-00687-0. Epub 2019 Jul 2.
|
| 545 |
KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis.Cancer Cell Int. 2019 Dec 3;19:325. doi: 10.1186/s12935-019-1039-z. eCollection 2019.
|
| 546 |
PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.IUBMB Life. 2018 Apr;70(4):291-299. doi: 10.1002/iub.1717. Epub 2018 Mar 8.
|
| 547 |
Importance of PNO1 for growth and survival of urinary bladder carcinoma: Role in core-regulatory circuitry.J Cell Mol Med. 2020 Jan;24(2):1504-1515. doi: 10.1111/jcmm.14835. Epub 2019 Dec 4.
|
| 548 |
A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese males.J Hum Genet. 2011 Aug;56(8):572-6. doi: 10.1038/jhg.2011.60. Epub 2011 Jul 7.
|
| 549 |
MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer.Mol Cancer Ther. 2018 Jul;17(7):1430-1440. doi: 10.1158/1535-7163.MCT-17-1049. Epub 2018 Apr 27.
|
| 550 |
RASSF6 Is Downregulated In Human Bladder Cancers And Regulates Doxorubicin Sensitivity And Mitochondrial Membrane Potential Via The Hippo Signaling Pathway.Onco Targets Ther. 2019 Nov 5;12:9189-9200. doi: 10.2147/OTT.S217041. eCollection 2019.
|
| 551 |
Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/-catenin feedback loop.FASEB J. 2019 Oct;33(10):10973-10985. doi: 10.1096/fj.201900537R. Epub 2019 Jul 18.
|
| 552 |
Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-B signaling.Biomed Pharmacother. 2019 Sep;117:109112. doi: 10.1016/j.biopha.2019.109112. Epub 2019 Jun 15.
|
| 553 |
Adseverin modulates morphology and invasive function of MCF7 cells.Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2716-2725. doi: 10.1016/j.bbadis.2019.07.015. Epub 2019 Jul 29.
|
| 554 |
SEC11A Expression Is Associated with Basal-Like Bladder Cancer and Predicts Patient Survival.Pathobiology. 2019;86(4):208-216. doi: 10.1159/000497206. Epub 2019 Jun 4.
|
| 555 |
CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.Cancer Sci. 2018 May;109(5):1723-1730. doi: 10.1111/cas.13565. Epub 2018 Apr 14.
|
| 556 |
Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.Onco Targets Ther. 2019 Dec 10;12:10771-10786. doi: 10.2147/OTT.S229332. eCollection 2019.
|
| 557 |
The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions.Life Sci. 2019 Sep 1;232:116614. doi: 10.1016/j.lfs.2019.116614. Epub 2019 Jun 28.
|
| 558 |
MiRNA-616 aggravates the progression of bladder cancer by regulating cell proliferation, migration and apoptosis through downregulating SOX7.Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9304-9312. doi: 10.26355/eurrev_201911_19423.
|
| 559 |
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients.Pathol Oncol Res. 2020 Apr;26(2):1243-1249. doi: 10.1007/s12253-019-00689-y. Epub 2019 Jun 27.
|
| 560 |
Repression of transcription factor AP-2 alpha by PPAR reveals a novel transcriptional circuit in basal-squamous bladder cancer.Oncogenesis. 2019 Nov 26;8(12):69. doi: 10.1038/s41389-019-0178-3.
|
| 561 |
The Pathological Significance and Prognostic Roles of Thrombospondin-1, and -2, and 4N1K-peptide in Bladder Cancer.Anticancer Res. 2019 May;39(5):2317-2324. doi: 10.21873/anticanres.13348.
|
| 562 |
Overexpression of thymosin 10 correlates with disease progression and poor prognosis in bladder cancer.Exp Ther Med. 2019 Nov;18(5):3759-3766. doi: 10.3892/etm.2019.8006. Epub 2019 Sep 13.
|
| 563 |
Expression of Testis-Specific Gene Antigen 10 (TSGA10) is Associated with Apoptosis and Cell Migration in Bladder Cancer Cells and Tumor Stage and Overall Survival in Patients with Bladder Cancer.Med Sci Monit. 2019 Jul 16;25:5289-5298. doi: 10.12659/MSM.915682.
|
| 564 |
The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24).DNA Cell Biol. 2014 Jul;33(7):408-17. doi: 10.1089/dna.2013.2285. Epub 2014 Mar 25.
|
| 565 |
Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer.Gene. 2017 Aug 30;626:407-413. doi: 10.1016/j.gene.2017.05.054. Epub 2017 May 25.
|
| 566 |
Increased expression of -actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.Oncol Rep. 2013 Sep;30(3):1073-80. doi: 10.3892/or.2013.2577. Epub 2013 Jul 1.
|
| 567 |
ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.PLoS One. 2016 Mar 1;11(3):e0150138. doi: 10.1371/journal.pone.0150138. eCollection 2016.
|
| 568 |
Deregulation of Rab and Rab effector genes in bladder cancer.PLoS One. 2012;7(6):e39469. doi: 10.1371/journal.pone.0039469. Epub 2012 Jun 19.
|
| 569 |
Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid Synthesis.Clin Cancer Res. 2016 Mar 1;22(5):1274-83. doi: 10.1158/1078-0432.CCR-15-1706. Epub 2015 Oct 21.
|
| 570 |
ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.Cancer Sci. 2013 Mar;104(3):321-7. doi: 10.1111/cas.12089. Epub 2013 Feb 14.
|
| 571 |
ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.Clin Cancer Res. 2012 Oct 1;18(19):5247-55. doi: 10.1158/1078-0432.CCR-12-0955. Epub 2012 Jul 31.
|
| 572 |
ALKBH8 promotes bladder cancer growth and progression through regulating the expression of survivin.Biochem Biophys Res Commun. 2016 Aug 26;477(3):413-8. doi: 10.1016/j.bbrc.2016.06.084. Epub 2016 Jun 18.
|
| 573 |
Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies.World J Urol. 2018 Jun;36(6):839-848. doi: 10.1007/s00345-018-2206-x. Epub 2018 Feb 5.
|
| 574 |
Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.Oncotarget. 2017 Apr 11;8(15):24262-24274. doi: 10.18632/oncotarget.10529.
|
| 575 |
Multitarget fluorescence in situ hybridization and melanoma antigen genes analysis in primary bladder carcinoma.Cancer Genet Cytogenet. 2006 Jan 1;164(1):32-8. doi: 10.1016/j.cancergencyto.2005.06.006.
|
| 576 |
Cross-species analysis of the canine and human bladder cancer transcriptome and exome.Genes Chromosomes Cancer. 2017 Apr;56(4):328-343. doi: 10.1002/gcc.22441. Epub 2017 Jan 25.
|
| 577 |
Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.Mol Oncol. 2019 Jul;13(7):1559-1576. doi: 10.1002/1878-0261.12523. Epub 2019 Jun 9.
|
| 578 |
Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.Nat Genet. 2016 Nov;48(11):1330-1338. doi: 10.1038/ng.3670. Epub 2016 Sep 19.
|
| 579 |
Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.Tumour Biol. 2014 Mar;35(3):2481-9. doi: 10.1007/s13277-013-1328-4. Epub 2013 Nov 11.
|
| 580 |
Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma.J Cancer. 2017 Sep 27;8(17):3490-3497. doi: 10.7150/jca.19109. eCollection 2017.
|
| 581 |
Identification and functional characterization of JWA polymorphisms and their association with risk of gastric cancer and esophageal squamous cell carcinoma in a Chinese population.J Toxicol Environ Health A. 2007 Jun;70(11):885-94. doi: 10.1080/15287390701285915.
|
| 582 |
Silencing of Armadillo Repeat-Containing Protein 8 (ARMc8) Inhibits TGF--Induced EMT in Bladder Carcinoma UMUC3 Cells.Oncol Res. 2017 Jan 2;25(1):99-105. doi: 10.3727/096504016X14719078133609.
|
| 583 |
Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.Oncol Lett. 2019 Feb;17(2):1865-1876. doi: 10.3892/ol.2018.9762. Epub 2018 Nov 26.
|
| 584 |
Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism.Theranostics. 2018 Aug 10;8(16):4520-4534. doi: 10.7150/thno.25130. eCollection 2018.
|
| 585 |
Association between AXIN1 Gene Polymorphisms and Bladder Cancer in Chinese Han Population.Dis Markers. 2019 Apr 15;2019:3949343. doi: 10.1155/2019/3949343. eCollection 2019.
|
| 586 |
B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.BMC Cancer. 2018 May 24;18(1):590. doi: 10.1186/s12885-018-4497-0.
|
| 587 |
Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.Aging (Albany NY). 2018 Oct 12;10(10):2606-2623. doi: 10.18632/aging.101573.
|
| 588 |
BAMBI gene is epigenetically silenced in subset of high-grade bladder cancer.Int J Cancer. 2009 Jul 15;125(2):328-38. doi: 10.1002/ijc.24318.
|
| 589 |
The role of Lutheran/basal cell adhesion molecule in human bladder carcinogenesis.J Biomed Sci. 2017 Aug 26;24(1):61. doi: 10.1186/s12929-017-0360-x.
|
| 590 |
BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress.Urol Oncol. 2010 May-Jun;28(3):334-7. doi: 10.1016/j.urolonc.2009.07.026.
|
| 591 |
Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.Anticancer Res. 2008 Jul-Aug;28(4B):2259-63.
|
| 592 |
Aristolochic acid I interferes with the expression of BLCAP tumor suppressor gene in human cells.Toxicol Lett. 2018 Jul;291:129-137. doi: 10.1016/j.toxlet.2018.03.032. Epub 2018 Apr 12.
|
| 593 |
Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer.J Exp Clin Cancer Res. 2017 Jun 9;36(1):77. doi: 10.1186/s13046-017-0542-0.
|
| 594 |
Circ-BPTF promotes bladder cancer progression and recurrence through the miR-31-5p/RAB27A axis.Aging (Albany NY). 2018 Aug 9;10(8):1964-1976. doi: 10.18632/aging.101520.
|
| 595 |
Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1483-91. doi: 10.1158/1055-9965.EPI-11-0067. Epub 2011 May 17.
|
| 596 |
The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.Clin Exp Metastasis. 2000;18(6):519-25. doi: 10.1023/a:1011819621859.
|
| 597 |
BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.Cancer Med. 2018 Jan;7(1):184-195. doi: 10.1002/cam4.1263. Epub 2017 Dec 13.
|
| 598 |
Lost expression of cell adhesion molecule 1 is associated with bladder cancer progression and recurrence and its overexpression inhibited tumor cell malignant behaviors.Oncol Lett. 2019 Feb;17(2):2047-2056. doi: 10.3892/ol.2018.9845. Epub 2018 Dec 18.
|
| 599 |
Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.Oncotarget. 2015 Nov 24;6(37):40370-84. doi: 10.18632/oncotarget.5458.
|
| 600 |
Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.Cancer Res. 1996 Aug 1;56(15):3431-5.
|
| 601 |
The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer.Cancer Gene Ther. 2020 Apr;27(3-4):189-202. doi: 10.1038/s41417-019-0085-y. Epub 2019 Feb 6.
|
| 602 |
Effects of tumor necrosis factor-alpha and interferon-gamma on expressions of matrix metalloproteinase-2 and -9 in human bladder cancer cells.Cancer Lett. 2000 Oct 31;159(2):127-34. doi: 10.1016/s0304-3835(00)00522-x.
|
| 603 |
CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.Oncotarget. 2015 Sep 22;6(28):25856-67. doi: 10.18632/oncotarget.4624.
|
| 604 |
Long noncoding RNAGAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (CC motif) ligand 1 expression.Mol Med Rep. 2016 Jan;13(1):27-34. doi: 10.3892/mmr.2015.4503. Epub 2015 Nov 5.
|
| 605 |
Establishment and characterization of two human bladder cancer cell lines.Hum Cell. 1996 Mar;9(1):49-56.
|
| 606 |
NOV is upregulated and promotes migration and invasion in bladder cancer.Tumour Biol. 2014 Jul;35(7):6749-55. doi: 10.1007/s13277-014-1919-8. Epub 2014 Apr 10.
|
| 607 |
The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer.Urol Oncol. 2016 May;34(5):237.e1-10. doi: 10.1016/j.urolonc.2015.11.011. Epub 2015 Dec 17.
|
| 608 |
High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.Carcinogenesis. 2007 Oct;28(10):2160-5. doi: 10.1093/carcin/bgm167. Epub 2007 Aug 29.
|
| 609 |
Rs6265 polymorphism in brain-derived neurotrophic factor (Val/Val and Val/Met) promotes proliferation of bladder cancer cells by suppressing microRNA-205 and enhancing expression of cyclin J.J Cell Biochem. 2019 May;120(5):7297-7308. doi: 10.1002/jcb.28004. Epub 2018 Nov 1.
|
| 610 |
CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.Cancer Med. 2018 Aug;7(8):3763-3772. doi: 10.1002/cam4.1607. Epub 2018 Jul 18.
|
| 611 |
Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancer.Biochem Biophys Res Commun. 2014 Jun 13;448(4):467-72. doi: 10.1016/j.bbrc.2014.04.137. Epub 2014 May 4.
|
| 612 |
Hypermethylation of E-cadherin, p16, p14, and RASSF1A genes in pathologically normal urothelium predict bladder recurrence of bladder cancer after transurethral resection.Urol Oncol. 2012 Mar-Apr;30(2):177-81. doi: 10.1016/j.urolonc.2010.01.002. Epub 2010 Aug 25.
|
| 613 |
Centromere protein U is a potential target for gene therapy of human bladder cancer.Oncol Rep. 2017 Aug;38(2):735-744. doi: 10.3892/or.2017.5769. Epub 2017 Jun 30.
|
| 614 |
Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway.Int J Cancer. 2019 Oct 15;145(8):2170-2181. doi: 10.1002/ijc.32311. Epub 2019 May 30.
|
| 615 |
miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2.Gene. 2019 Jun 15;701:23-31. doi: 10.1016/j.gene.2019.02.083. Epub 2019 Mar 19.
|
| 616 |
Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):231-235. doi: 10.1016/j.bbrc.2018.11.013. Epub 2018 Nov 12.
|
| 617 |
Electrochemical ELISA-based platform for bladder cancer protein biomarker detection in urine.Biosens Bioelectron. 2018 Oct 15;117:620-627. doi: 10.1016/j.bios.2018.07.003. Epub 2018 Jul 3.
|
| 618 |
miR-182-5p affects human bladder cancer cell proliferation, migration and invasion through regulating Cofilin 1.Cancer Cell Int. 2019 Feb 28;19:42. doi: 10.1186/s12935-019-0758-5. eCollection 2019.
|
| 619 |
Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing.Oncotarget. 2016 Jan 19;7(3):2629-45. doi: 10.18632/oncotarget.6380.
|
| 620 |
Decreased expression of p57(KIP2)mRNA in human bladder cancer.Br J Cancer. 2000 Sep;83(5):626-31. doi: 10.1054/bjoc.2000.1298.
|
| 621 |
CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.Oncol Rep. 2018 Nov;40(5):2445-2454. doi: 10.3892/or.2018.6641. Epub 2018 Aug 10.
|
| 622 |
Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression.J Int Med Res. 2011;39(2):533-40. doi: 10.1177/147323001103900222.
|
| 623 |
CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor.BMC Cancer. 2017 Feb 6;17(1):105. doi: 10.1186/s12885-017-3101-3.
|
| 624 |
Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.Oncotarget. 2019 Jan 29;10(9):1010. doi: 10.18632/oncotarget.26656. eCollection 2019 Jan 29.
|
| 625 |
CLT1 targets bladder cancer through integrin 51 and CLIC3.Mol Cancer Res. 2013 Feb;11(2):194-203. doi: 10.1158/1541-7786.MCR-12-0300. Epub 2012 Nov 30.
|
| 626 |
Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.Tumour Biol. 2016 May;37(5):6217-25. doi: 10.1007/s13277-015-4508-6. Epub 2015 Nov 28.
|
| 627 |
Risk score based on three mRNA expression predicts the survival of bladder cancer.Oncotarget. 2017 Jun 27;8(37):61583-61591. doi: 10.18632/oncotarget.18642. eCollection 2017 Sep 22.
|
| 628 |
The clinical significance of COL5A2 in patients with bladder cancer: A retrospective analysis of bladder cancer gene expression data.Medicine (Baltimore). 2018 Mar;97(10):e0091. doi: 10.1097/MD.0000000000010091.
|
| 629 |
High expression of constitutive photomorphogenic 1 (COP1) is associated with poor prognosis in bladder cancer.Tumour Biol. 2016 Jul;37(7):8917-22. doi: 10.1007/s13277-015-4765-4. Epub 2016 Jan 11.
|
| 630 |
Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A.Oncotarget. 2019 Aug 27;10(50):5168-5180. doi: 10.18632/oncotarget.27125. eCollection 2019 Aug 27.
|
| 631 |
Single-cell RNA-seq analysis reveals the platinum resistance gene COX7B and the surrogate marker CD63.Cancer Med. 2018 Dec;7(12):6193-6204. doi: 10.1002/cam4.1828. Epub 2018 Oct 26.
|
| 632 |
Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.Breast Cancer Res. 2016 Jan 25;18(1):12. doi: 10.1186/s13058-016-0672-x.
|
| 633 |
The role of CT10 regulation of kinase-like in cancer.Future Oncol. 2014 Dec;10(16):2687-97. doi: 10.2217/fon.14.199.
|
| 634 |
CSTF2-Induced Shortening of the RAC1 3'UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder.Cancer Res. 2018 Oct 15;78(20):5848-5862. doi: 10.1158/0008-5472.CAN-18-0822. Epub 2018 Aug 24.
|
| 635 |
Dysregulated genes targeted by microRNAs and metabolic pathways in bladder cancer revealed by bioinformatics methods.Oncol Lett. 2018 Jun;15(6):9617-9624. doi: 10.3892/ol.2018.8602. Epub 2018 Apr 27.
|
| 636 |
CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/-catenin signaling pathway.Oncotarget. 2017 Aug 24;8(44):77241-77253. doi: 10.18632/oncotarget.20455. eCollection 2017 Sep 29.
|
| 637 |
Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.Cancer Res. 2016 Jun 1;76(11):3277-84. doi: 10.1158/0008-5472.CAN-15-2564. Epub 2016 Mar 29.
|
| 638 |
CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-B pathway.Biochem Biophys Res Commun. 2018 Apr 15;498(4):862-868. doi: 10.1016/j.bbrc.2018.03.071. Epub 2018 Mar 17.
|
| 639 |
Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer.Cancer Res. 2008 Feb 1;68(3):700-6. doi: 10.1158/0008-5472.CAN-07-5532.
|
| 640 |
Estrogen receptor promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals.Exp Mol Med. 2018 Nov 20;50(11):1-11. doi: 10.1038/s12276-018-0155-5.
|
| 641 |
DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.PLoS One. 2016 Dec 1;11(12):e0167228. doi: 10.1371/journal.pone.0167228. eCollection 2016.
|
| 642 |
The prognostic significance of DAPK1 in bladder cancer.PLoS One. 2017 Apr 7;12(4):e0175290. doi: 10.1371/journal.pone.0175290. eCollection 2017.
|
| 643 |
Drebrin at Junctional Plaques.Adv Exp Med Biol. 2017;1006:313-328. doi: 10.1007/978-4-431-56550-5_18.
|
| 644 |
Use of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agents.Neoplasia. 2011 Jan;13(1):72-80. doi: 10.1593/neo.101214.
|
| 645 |
Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.Carcinogenesis. 2018 Mar 8;39(3):482-492. doi: 10.1093/carcin/bgy015.
|
| 646 |
DCAMKL1 is associated with the malignant status and poor outcome in bladder cancer.Tumour Biol. 2017 Jun;39(6):1010428317703822. doi: 10.1177/1010428317703822.
|
| 647 |
Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.Cancer Res. 2008 Apr 1;68(7):2530-7. doi: 10.1158/0008-5472.CAN-07-5991.
|
| 648 |
DDX39 acts as a suppressor of invasion for bladder cancer.Cancer Sci. 2012 Jul;103(7):1363-9. doi: 10.1111/j.1349-7006.2012.02298.x. Epub 2012 Jun 4.
|
| 649 |
miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.Oncol Rep. 2017 Feb;37(2):1123-1131. doi: 10.3892/or.2016.5326. Epub 2016 Dec 16.
|
| 650 |
Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.Oncotarget. 2017 Mar 7;8(10):17059-17069. doi: 10.18632/oncotarget.15001.
|
| 651 |
Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis.Exp Cell Res. 2015 Feb 15;331(2):399-407. doi: 10.1016/j.yexcr.2014.11.015. Epub 2014 Dec 3.
|
| 652 |
Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis.Clin Biochem. 2014 Jan;47(1-2):104-10. doi: 10.1016/j.clinbiochem.2013.10.022. Epub 2013 Oct 29.
|
| 653 |
Detection of deleted in malignant brain tumors 1 and runt-related transcription factor 3 gene expressions in bladder carcinoma.Mol Biol Rep. 2012 Apr;39(4):4691-5. doi: 10.1007/s11033-011-1261-9. Epub 2011 Sep 29.
|
| 654 |
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.Oncogene. 2017 Jan 5;36(1):35-46. doi: 10.1038/onc.2016.172. Epub 2016 Jun 6.
|
| 655 |
MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.Oncotarget. 2015 Jun 30;6(18):16043-58. doi: 10.18632/oncotarget.3755.
|
| 656 |
Luteolin induces N-acetylation and DNA adduct of 2-aminofluorene accompanying N-acetyltransferase activity and gene expression in human bladder cancer T24 cell line.Anticancer Res. 2003 Jan-Feb;23(1A):355-62.
|
| 657 |
Genetic variation in DROSHA 3'UTR regulated by hsa-miR-27b is associated with bladder cancer risk.PLoS One. 2013 Nov 28;8(11):e81524. doi: 10.1371/journal.pone.0081524. eCollection 2013.
|
| 658 |
DUOX2 promotes the elimination of the Klebsiella pneumoniae strainK5 from T24 cells through the reactive oxygen species pathway.Int J Mol Med. 2015 Aug;36(2):551-8. doi: 10.3892/ijmm.2015.2234. Epub 2015 Jun 3.
|
| 659 |
E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer.Mol Cancer Res. 2015 Sep;13(9):1316-24. doi: 10.1158/1541-7786.MCR-15-0120. Epub 2015 Jun 1.
|
| 660 |
Silencing of ECHDC1 inhibits growth of gemcitabine-resistant bladder cancer cells.Oncol Lett. 2018 Jan;15(1):522-527. doi: 10.3892/ol.2017.7269. Epub 2017 Oct 26.
|
| 661 |
Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression.J Urol. 2014 Aug;192(2):583-92. doi: 10.1016/j.juro.2014.02.035. Epub 2014 Feb 14.
|
| 662 |
Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer.Int J Cancer. 2015 Feb 1;136(3):709-20. doi: 10.1002/ijc.29022. Epub 2014 Jul 22.
|
| 663 |
Inhibition of angiogenesis by leflunomide via targeting the soluble ephrin-A1/EphA2 system in bladder cancer.Sci Rep. 2018 Jan 24;8(1):1539. doi: 10.1038/s41598-018-19788-y.
|
| 664 |
Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy.World J Surg Oncol. 2017 Mar 20;15(1):66. doi: 10.1186/s12957-017-1125-4.
|
| 665 |
Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.Clin Cancer Res. 2013 Jun 1;19(11):2850-60. doi: 10.1158/1078-0432.CCR-12-3084. Epub 2013 Apr 10.
|
| 666 |
Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.Gene. 2016 Oct 30;592(1):78-85. doi: 10.1016/j.gene.2016.07.042. Epub 2016 Jul 20.
|
| 667 |
Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.Int J Mol Sci. 2018 Mar 8;19(3):777. doi: 10.3390/ijms19030777.
|
| 668 |
Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.Oncol Rep. 2015 May;33(5):2319-30. doi: 10.3892/or.2015.3858. Epub 2015 Mar 17.
|
| 669 |
Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation.PLoS One. 2012;7(10):e46297. doi: 10.1371/journal.pone.0046297. Epub 2012 Oct 3.
|
| 670 |
Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus.Biomarkers. 2014 Sep;19(6):509-16. doi: 10.3109/1354750X.2014.943291. Epub 2014 Aug 4.
|
| 671 |
Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.Tumour Biol. 2016 Apr;37(4):5165-70. doi: 10.1007/s13277-015-4375-1. Epub 2015 Nov 7.
|
| 672 |
Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.Cancer Invest. 2008 Aug;26(7):725-33. doi: 10.1080/07357900801941845.
|
| 673 |
Transcriptional regulatory networks in human lung adenocarcinoma.Mol Med Rep. 2012 Nov;6(5):961-6. doi: 10.3892/mmr.2012.1034. Epub 2012 Aug 14.
|
| 674 |
OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells.J Cancer. 2018 Nov 24;9(24):4684-4695. doi: 10.7150/jca.27381. eCollection 2018.
|
| 675 |
Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.Urol Oncol. 2019 Jan;37(1):86-96. doi: 10.1016/j.urolonc.2018.10.023. Epub 2018 Nov 13.
|
| 676 |
Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid.Toxins (Basel). 2016 Jul 8;8(7):211. doi: 10.3390/toxins8070211.
|
| 677 |
Fibulin-1 is epigenetically down-regulated and related with bladder cancer recurrence.BMC Cancer. 2014 Sep 18;14:677. doi: 10.1186/1471-2407-14-677.
|
| 678 |
Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637.Urol Oncol. 2011 Jul-Aug;29(4):430-5. doi: 10.1016/j.urolonc.2009.06.004. Epub 2009 Sep 19.
|
| 679 |
Role of the focal adhesion protein kindlin-1 in breast cancer growth and lung metastasis.J Natl Cancer Inst. 2011 Sep 7;103(17):1323-37. doi: 10.1093/jnci/djr290. Epub 2011 Aug 10.
|
| 680 |
Prognostic value of Kindlin-2 expression in patients with solid tumors: a meta-analysis.Cancer Cell Int. 2018 Oct 22;18:166. doi: 10.1186/s12935-018-0651-7. eCollection 2018.
|
| 681 |
Molecular genetics of bladder cancer: targets for diagnosis and therapy.J Exp Clin Cancer Res. 2006 Jun;25(2):145-60.
|
| 682 |
Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-B signaling pathway.Lab Invest. 2018 Sep;98(9):1225-1236. doi: 10.1038/s41374-018-0077-9. Epub 2018 Jun 20.
|
| 683 |
Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1.Signal Transduct Target Ther. 2017;2:16045-. doi: 10.1038/sigtrans.2016.45. Epub 2017 Mar 17.
|
| 684 |
The evolving understanding of microRNA in bladder cancer.Urol Oncol. 2014 Jan;32(1):41.e31-40. doi: 10.1016/j.urolonc.2013.04.014. Epub 2013 Aug 2.
|
| 685 |
MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.Am J Cancer Res. 2017 Aug 1;7(8):1738-1753. eCollection 2017.
|
| 686 |
Genome-wide interaction study of smoking and bladder cancer risk.Carcinogenesis. 2014 Aug;35(8):1737-44. doi: 10.1093/carcin/bgu064. Epub 2014 Mar 24.
|
| 687 |
Hypermethylation of FOXA1 and allelic loss of PTEN drive squamous differentiation and promote heterogeneity in bladder cancer.Oncogene. 2020 Feb;39(6):1302-1317. doi: 10.1038/s41388-019-1063-4. Epub 2019 Oct 21.
|
| 688 |
On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.Nat Rev Urol. 2017 Feb;14(2):98-106. doi: 10.1038/nrurol.2016.239. Epub 2016 Nov 29.
|
| 689 |
Forkhead box O-class 1 and forkhead box G1 as prognostic markers for bladder cancer.J Korean Med Sci. 2009 Jun;24(3):468-73. doi: 10.3346/jkms.2009.24.3.468. Epub 2009 Jun 12.
|
| 690 |
Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.Pathol Res Pract. 2017 Jul;213(7):766-772. doi: 10.1016/j.prp.2017.04.004. Epub 2017 Apr 20.
|
| 691 |
MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer.Neoplasma. 2018;65(1):89-96. doi: 10.4149/neo_2018_161128N594.
|
| 692 |
Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K/AKT pathway.Onco Targets Ther. 2018 Apr 5;11:1961-1971. doi: 10.2147/OTT.S158275. eCollection 2018.
|
| 693 |
MicroRNA-101 inhibits cell migration and invasion in bladder cancer via targeting FZD4.Exp Ther Med. 2019 Feb;17(2):1476-1485. doi: 10.3892/etm.2018.7084. Epub 2018 Dec 11.
|
| 694 |
GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer.Onco Targets Ther. 2019 Sep 16;12:7591-7599. doi: 10.2147/OTT.S222223. eCollection 2019.
|
| 695 |
ppGalNAc T1 as a potential novel marker for human bladder cancer.Asian Pac J Cancer Prev. 2012;13(11):5653-7. doi: 10.7314/apjcp.2012.13.11.5653.
|
| 696 |
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.Cancer Res. 1996 Nov 1;56(21):5039-43.
|
| 697 |
Puerarin Inhibits Proliferation and Induces Apoptosis by Upregulation of miR-16 in Bladder Cancer Cell Line T24.Oncol Res. 2018 Sep 14;26(8):1227-1234. doi: 10.3727/096504018X15178736525106. Epub 2018 Feb 8.
|
| 698 |
Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.Int J Mol Med. 2012 Mar;29(3):428-34. doi: 10.3892/ijmm.2011.858. Epub 2011 Dec 12.
|
| 699 |
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14884-9. doi: 10.1073/pnas.0902042106. Epub 2009 Aug 17.
|
| 700 |
Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.Jpn J Clin Oncol. 2015 Nov;45(11):1055-63. doi: 10.1093/jjco/hyv132. Epub 2015 Sep 14.
|
| 701 |
Association of GNB4 intron-1 haplotypes with survival in patients with UICC stage III and IV colorectal carcinoma.Anticancer Res. 2009 Apr;29(4):1271-4.
|
| 702 |
Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.Cell Prolif. 2009 Dec;42(6):762-9. doi: 10.1111/j.1365-2184.2009.00635.x. Epub 2009 Aug 25.
|
| 703 |
GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-1/Smad2 signalling pathway.J Cell Mol Med. 2018 Mar;22(3):1650-1665. doi: 10.1111/jcmm.13442. Epub 2018 Jan 19.
|
| 704 |
Protein kinase C- (PKC) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.BMC Cancer. 2017 Jun 19;17(1):432. doi: 10.1186/s12885-017-3401-7.
|
| 705 |
Profiling the expression pattern of GPI transamidase complex subunits in human cancer.Mod Pathol. 2008 Aug;21(8):979-91. doi: 10.1038/modpathol.2008.76. Epub 2008 May 16.
|
| 706 |
circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide.Mol Ther Nucleic Acids. 2018 Dec 7;13:633-641. doi: 10.1016/j.omtn.2018.10.008. Epub 2018 Oct 18.
|
| 707 |
Identification of new hub genes associated with bladder carcinoma via bioinformatics analysis.Tumori. 2015 Jan-Feb;101(1):117-22. doi: 10.5301/tj.5000196. Epub 2015 Feb 6.
|
| 708 |
Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA-eGREB1.J Cell Mol Med. 2018 Dec;22(12):5919-5927. doi: 10.1111/jcmm.13861. Epub 2018 Sep 4.
|
| 709 |
Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer.Cytogenet Cell Genet. 2000;91(1-4):234-8. doi: 10.1159/000056851.
|
| 710 |
The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.J Proteomics. 2017 Mar 6;156:94-103. doi: 10.1016/j.jprot.2017.01.013. Epub 2017 Jan 27.
|
| 711 |
The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.PLoS One. 2013 Sep 17;8(9):e75681. doi: 10.1371/journal.pone.0075681. eCollection 2013.
|
| 712 |
The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression.Cell Death Dis. 2014 Sep 4;5(9):e1402. doi: 10.1038/cddis.2014.367.
|
| 713 |
Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPAR-SIRT1 feedback loop.J Cancer. 2017 Jul 20;8(12):2282-2295. doi: 10.7150/jca.19967. eCollection 2017.
|
| 714 |
Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk.Tumour Biol. 2014 Feb;35(2):1139-42. doi: 10.1007/s13277-013-1152-x. Epub 2013 Sep 8.
|
| 715 |
Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.Genet Test Mol Biomarkers. 2015 Jun;19(6):309-15. doi: 10.1089/gtmb.2015.0050. Epub 2015 May 8.
|
| 716 |
Human HLAF adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.Mol Med Rep. 2018 Jul;18(1):308-314. doi: 10.3892/mmr.2018.9005. Epub 2018 May 9.
|
| 717 |
Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/-catenin signaling.Chem Biol Interact. 2019 Feb 25;300:73-81. doi: 10.1016/j.cbi.2019.01.015. Epub 2019 Jan 11.
|
| 718 |
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.Cancer. 2011 Mar 15;117(6):1197-209. doi: 10.1002/cncr.25565. Epub 2010 Oct 19.
|
| 719 |
Expression of HNF4G and its potential functions in lung cancer.Oncotarget. 2017 Dec 4;9(26):18018-18028. doi: 10.18632/oncotarget.22933. eCollection 2018 Apr 6.
|
| 720 |
MicroRNA-146b Overexpression Promotes Human Bladder Cancer Invasion via Enhancing ETS2-Mediated mmp2 mRNA Transcription.Mol Ther Nucleic Acids. 2019 Jun 7;16:531-542. doi: 10.1016/j.omtn.2019.04.007. Epub 2019 Apr 14.
|
| 721 |
HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer.Am J Transl Res. 2019 Nov 15;11(11):7035-7048. eCollection 2019.
|
| 722 |
Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2.Clin Cancer Res. 2019 Feb 15;25(4):1389-1403. doi: 10.1158/1078-0432.CCR-18-1656. Epub 2018 Nov 5.
|
| 723 |
HnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathways.Oncotarget. 2017 Feb 21;8(8):13586-13599. doi: 10.18632/oncotarget.14600.
|
| 724 |
The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.Int J Cancer. 2012 Aug 1;131(3):E179-89. doi: 10.1002/ijc.26501. Epub 2011 Dec 21.
|
| 725 |
Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer.Medicine (Baltimore). 2018 Aug;97(35):e11887. doi: 10.1097/MD.0000000000011887.
|
| 726 |
MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene.Cancer Lett. 2015 Feb 1;357(1):105-113. doi: 10.1016/j.canlet.2014.11.002. Epub 2014 Nov 11.
|
| 727 |
MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.Oncol Rep. 2014 Apr;31(4):1832-8. doi: 10.3892/or.2014.3048. Epub 2014 Feb 24.
|
| 728 |
Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines.Cancer Lett. 1997 Oct 28;119(1):63-70. doi: 10.1016/s0304-3835(97)00255-3.
|
| 729 |
Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.Eur J Cancer. 2010 Jan;46(1):207-15. doi: 10.1016/j.ejca.2009.10.020.
|
| 730 |
Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model.Urol Oncol. 2006 Jul-Aug;24(4):362-71. doi: 10.1016/j.urolonc.2005.11.028.
|
| 731 |
Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.Mol Cancer. 2005 May 5;4(1):16. doi: 10.1186/1476-4598-4-16.
|
| 732 |
Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer.BMC Urol. 2018 Sep 24;18(1):82. doi: 10.1186/s12894-018-0388-6.
|
| 733 |
Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA.Oncogene. 1994 Sep;9(9):2757-60.
|
| 734 |
Anti-interleukin-10R1 monoclonal antibody in combination with bacillus Calmette--Gurin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti-tumour immunity.Clin Exp Immunol. 2014 Jul;177(1):261-8. doi: 10.1111/cei.12315.
|
| 735 |
Continuous activation of primitive hematopoietic cells in long-term human marrow cultures containing irradiated tumor cells.J Cell Physiol. 1991 Sep;148(3):370-9. doi: 10.1002/jcp.1041480307.
|
| 736 |
TGF1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.Theranostics. 2017 Jul 22;7(12):3053-3067. doi: 10.7150/thno.19542. eCollection 2017.
|
| 737 |
Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.Mol Biol Rep. 2015 Feb;42(2):507-16. doi: 10.1007/s11033-014-3794-1. Epub 2014 Oct 17.
|
| 738 |
Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.Cancer. 2012 Jan 1;118(1):205-15. doi: 10.1002/cncr.26224. Epub 2011 Jun 20.
|
| 739 |
Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder.Urol Int. 2015;94(4):464-71. doi: 10.1159/000364832. Epub 2015 Mar 14.
|
| 740 |
The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.Oncotarget. 2015 Apr 30;6(12):10195-206. doi: 10.18632/oncotarget.3555.
|
| 741 |
Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo.Oncotarget. 2014 Sep 15;5(17):7917-35. doi: 10.18632/oncotarget.1421.
|
| 742 |
SKIP expression is correlated with clinical prognosis in patients with bladder cancer.Int J Clin Exp Pathol. 2014 Mar 15;7(4):1695-701. eCollection 2014.
|
| 743 |
Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors.Mol Cancer Res. 2015 Sep;13(9):1306-15. doi: 10.1158/1541-7786.MCR-15-0130. Epub 2015 Jun 15.
|
| 744 |
MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.Cancer Biomark. 2019;24(2):159-172. doi: 10.3233/CBM-182000.
|
| 745 |
Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.Carcinogenesis. 2014 Mar;35(3):727-36. doi: 10.1093/carcin/bgt375. Epub 2013 Nov 21.
|
| 746 |
Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.Life Sci. 2019 Aug 1;230:162-168. doi: 10.1016/j.lfs.2019.05.053. Epub 2019 May 21.
|
| 747 |
HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/-catenin signaling.Mol Carcinog. 2018 Jan;57(1):12-21. doi: 10.1002/mc.22715. Epub 2017 Sep 2.
|
| 748 |
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.Sci Transl Med. 2017 Feb 22;9(378):eaai8312. doi: 10.1126/scitranslmed.aai8312.
|
| 749 |
Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population.Mol Biol Rep. 2014 Feb;41(2):799-807. doi: 10.1007/s11033-013-2919-2. Epub 2014 Jan 4.
|
| 750 |
Role of a Kinesin Motor in Cancer Cell Mechanics.Nano Lett. 2019 Nov 13;19(11):7691-7702. doi: 10.1021/acs.nanolett.9b02592. Epub 2019 Oct 7.
|
| 751 |
A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells.Mol Cancer Ther. 2016 Sep;15(9):2066-75. doi: 10.1158/1535-7163.MCT-16-0010. Epub 2016 Jul 12.
|
| 752 |
The lncRNA ELF3-AS1 promotes bladder cancer progression by interaction with Krppel-like factor 8.Biochem Biophys Res Commun. 2019 Jan 15;508(3):762-768. doi: 10.1016/j.bbrc.2018.11.183. Epub 2018 Dec 7.
|
| 753 |
Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.Int J Cancer. 2002 Apr 1;98(4):630-5. doi: 10.1002/ijc.10246.
|
| 754 |
Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.J Cancer Res Clin Oncol. 2017 Mar;143(3):521-532. doi: 10.1007/s00432-016-2301-6. Epub 2016 Nov 17.
|
| 755 |
Single-cell Sequencing Reveals Variants in ARID1A, GPRC5A and MLL2 Driving Self-renewal of Human Bladder Cancer Stem Cells.Eur Urol. 2017 Jan;71(1):8-12. doi: 10.1016/j.eururo.2016.06.025. Epub 2016 Jul 4.
|
| 756 |
Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.Oncotarget. 2016 Nov 8;7(45):72767-72776. doi: 10.18632/oncotarget.11889.
|
| 757 |
Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis.Exp Biol Med (Maywood). 2018 Feb;243(4):344-349. doi: 10.1177/1535370218754493. Epub 2018 Jan 19.
|
| 758 |
Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.Asia Pac J Clin Oncol. 2019 Apr;15(2):e11-e19. doi: 10.1111/ajco.13024. Epub 2018 Jun 22.
|
| 759 |
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival.Virchows Arch. 2017 Mar;470(3):267-274. doi: 10.1007/s00428-017-2064-8. Epub 2017 Jan 10.
|
| 760 |
Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer.Clin Genitourin Cancer. 2017 Aug;15(4):455-462. doi: 10.1016/j.clgc.2016.11.005. Epub 2016 Dec 1.
|
| 761 |
Drug-induced keratin 9 interaction with Hsp70 in bladder cancer cells.Cell Stress Chaperones. 2018 Sep;23(5):1137-1142. doi: 10.1007/s12192-018-0913-2. Epub 2018 May 25.
|
| 762 |
Evaluation of the cytotoxic and pro-apoptotic activities of Eu(III) complexes with appended DNA intercalators in a panel of human malignant cell lines.Med Chem. 2006 Sep;2(5):439-45. doi: 10.2174/157340606778250234.
|
| 763 |
Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.Int J Oncol. 2017 Jan;50(1):263-271. doi: 10.3892/ijo.2016.3788. Epub 2016 Dec 5.
|
| 764 |
A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.PLoS One. 2015 Dec 10;10(12):e0144484. doi: 10.1371/journal.pone.0144484. eCollection 2015.
|
| 765 |
Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer.Oncotarget. 2017 Mar 28;8(13):21871-21883. doi: 10.18632/oncotarget.15669.
|
| 766 |
Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.Oncol Rep. 2017 Nov;38(5):2935-2940. doi: 10.3892/or.2017.5959. Epub 2017 Sep 18.
|
| 767 |
An enhanced hTERT promoter-driven CRISPR/Cas9 system selectively inhibits the progression of bladder cancer cells.Mol Biosyst. 2017 Aug 22;13(9):1713-1721. doi: 10.1039/c7mb00354d.
|
| 768 |
Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.Cancer Res. 2007 Feb 1;67(3):1212-20. doi: 10.1158/0008-5472.CAN-06-3283.
|
| 769 |
Genetic variation in the base excision repair pathway and bladder cancer risk.Hum Genet. 2007 Apr;121(2):233-42. doi: 10.1007/s00439-006-0294-y. Epub 2007 Jan 3.
|
| 770 |
MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.Oncogene. 2016 Mar 10;35(10):1292-301. doi: 10.1038/onc.2015.187. Epub 2015 Jun 1.
|
| 771 |
Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population. PLoS One. 2012;7(4):e35175.
|
| 772 |
LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.Cancer Res. 2007 May 1;67(9):4123-9. doi: 10.1158/0008-5472.CAN-07-0012. Epub 2007 Apr 24.
|
| 773 |
Lysyl oxidase family members in urological tumorigenesis and fibrosis.Oncotarget. 2018 Apr 13;9(28):20156-20164. doi: 10.18632/oncotarget.24948. eCollection 2018 Apr 13.
|
| 774 |
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.Cell Physiol Biochem. 2018;47(6):2250-2260. doi: 10.1159/000491536. Epub 2018 Jul 5.
|
| 775 |
Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.J Natl Cancer Inst. 1986 Aug;77(2):379-85.
|
| 776 |
Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.Mol Cancer Ther. 2019 Feb;18(2):413-420. doi: 10.1158/1535-7163.MCT-17-1079. Epub 2018 Oct 31.
|
| 777 |
Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.Clin Chim Acta. 2019 Apr;491:1-7. doi: 10.1016/j.cca.2019.01.003. Epub 2019 Jan 7.
|
| 778 |
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.J Biol Chem. 2013 Feb 8;288(6):3727-38. doi: 10.1074/jbc.M112.417568. Epub 2012 Dec 28.
|
| 779 |
Elevated TRIP13 drives cell proliferation and drug resistance in bladder cancer.Am J Transl Res. 2019 Jul 15;11(7):4397-4410. eCollection 2019.
|
| 780 |
MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.Gene. 2018 Dec 30;679:314-319. doi: 10.1016/j.gene.2018.09.022. Epub 2018 Sep 12.
|
| 781 |
STOP smoking and alcohol drinking before OPeration for bladder cancer ?the STOP-OP study),?perioperative smoking and alcohol cessation intervention in relation to radical cystectomy: study protocol for a randomised controlled trial.Trials. 2017 Jul 17;18(1):329. doi: 10.1186/s13063-017-2065-6.
|
| 782 |
Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.Cancer Res. 2003 Nov 15;63(22):7936-41.
|
| 783 |
X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism.Sci Adv. 2018 Jun 13;4(6):eaar5598. doi: 10.1126/sciadv.aar5598. eCollection 2018 Jun.
|
| 784 |
Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer.Cell Physiol Biochem. 2017;42(6):2404-2417. doi: 10.1159/000480182. Epub 2017 Aug 21.
|
| 785 |
CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.Mol Carcinog. 2015 Nov;54(11):1451-66. doi: 10.1002/mc.22222. Epub 2014 Sep 27.
|
| 786 |
A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer.Oncotarget. 2015 Jan 1;6(1):484-93. doi: 10.18632/oncotarget.2861.
|
| 787 |
The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.Oncol Lett. 2018 Sep;16(3):3013-3021. doi: 10.3892/ol.2018.9014. Epub 2018 Jun 25.
|
| 788 |
Knockdown of mediator subunit Med19 suppresses bladder cancer cell proliferation and migration by downregulating Wnt/-catenin signalling pathway.J Cell Mol Med. 2017 Dec;21(12):3254-3263. doi: 10.1111/jcmm.13229. Epub 2017 Jun 19.
|
| 789 |
The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.Anticancer Res. 2017 Dec;37(12):6685-6695. doi: 10.21873/anticanres.12127.
|
| 790 |
Identification of hMex-3A and its effect on human bladder cancer cell proliferation.Oncotarget. 2017 May 22;8(37):61215-61225. doi: 10.18632/oncotarget.18050. eCollection 2017 Sep 22.
|
| 791 |
Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt/-catenin pathway.Oncol Lett. 2019 Sep;18(3):2434-2442. doi: 10.3892/ol.2019.10570. Epub 2019 Jul 5.
|
| 792 |
MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer.Mol Ther Nucleic Acids. 2018 Jun 1;11:312-322. doi: 10.1016/j.omtn.2018.03.003. Epub 2018 Mar 10.
|
| 793 |
MMP23B expression and protein levels in blood and urine are associated with bladder cancer.Carcinogenesis. 2018 Oct 8;39(10):1254-1263. doi: 10.1093/carcin/bgy098.
|
| 794 |
Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis.Cancer Biomark. 2019;24(2):183-193. doi: 10.3233/CBM-181940.
|
| 795 |
Motor neuron and pancreas homeobox1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.J Exp Clin Cancer Res. 2018 Jul 16;37(1):154. doi: 10.1186/s13046-018-0829-9.
|
| 796 |
Transforming genes in human tumors.J Cell Biochem. 1982;20(1):51-61. doi: 10.1002/jcb.240200106.
|
| 797 |
Association of the PIG3 promoter polymorphism with invasive bladder cancer in a Japanese population.Jpn J Clin Oncol. 2006 Feb;36(2):116-20. doi: 10.1093/jjco/hyi225. Epub 2006 Jan 17.
|
| 798 |
Large-scale pathway-based analysis of bladder cancer genome-wide association data from five studies of European background.PLoS One. 2012;7(1):e29396. doi: 10.1371/journal.pone.0029396. Epub 2012 Jan 4.
|
| 799 |
Reduced Expression of Metastasis Suppressor-1 (MTSS1) Accelerates Progression of Human Bladder Uroepithelium Cell Carcinoma.Anticancer Res. 2017 Aug;37(8):4499-4505. doi: 10.21873/anticanres.11846.
|
| 800 |
Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.BMC Cancer. 2014 Mar 20;14:214. doi: 10.1186/1471-2407-14-214.
|
| 801 |
Variants of MUC5B minisatellites and the susceptibility of bladder cancer.DNA Cell Biol. 2009 Apr;28(4):169-76. doi: 10.1089/dna.2008.0827.
|
| 802 |
The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine.J Cancer Res Clin Oncol. 2008 Jun;134(6):659-65. doi: 10.1007/s00432-007-0331-9. Epub 2007 Nov 20.
|
| 803 |
The Association of MYNN and TERC Gene Polymorphisms and Bladder Cancer in a Turkish Population.Urol J. 2019 Feb 21;16(1):50-55. doi: 10.22037/uj.v0i0.4083.
|
| 804 |
Characterization of inflammasome-related genes in urine sediments of patients receiving intravesical BCG therapy.Urol Oncol. 2017 Dec;35(12):674.e19-674.e24. doi: 10.1016/j.urolonc.2017.08.004. Epub 2017 Sep 6.
|
| 805 |
Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.Lab Invest. 2017 May;97(5):567-576. doi: 10.1038/labinvest.2017.17. Epub 2017 Feb 27.
|
| 806 |
Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non-muscle-invasive Bladder Cancer.Eur Urol Oncol. 2019 Jul;2(4):381-389. doi: 10.1016/j.euo.2018.08.020. Epub 2018 Sep 15.
|
| 807 |
NBS1 Glu185Gln polymorphism and susceptibility to urinary system cancer: a meta-analysis.Tumour Biol. 2014 Nov;35(11):10723-9. doi: 10.1007/s13277-014-2346-6. Epub 2014 Jul 30.
|
| 808 |
LASP2 suppressed malignancy and Wnt/-catenin signaling pathway activation in bladder cancer.Exp Ther Med. 2018 Dec;16(6):5215-5223. doi: 10.3892/etm.2018.6836. Epub 2018 Oct 9.
|
| 809 |
Analysis of nm23 gene expressions in human bladder and renal cancers.Int J Urol. 1994 Dec;1(4):324-31. doi: 10.1111/j.1442-2042.1994.tb00058.x.
|
| 810 |
Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia.Oncogene. 2007 Feb 1;26(5):765-73. doi: 10.1038/sj.onc.1209835. Epub 2006 Jul 31.
|
| 811 |
A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression.Cancer Res. 2009 Apr 1;69(7):3157-64. doi: 10.1158/0008-5472.CAN-08-3530. Epub 2009 Mar 17.
|
| 812 |
The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.Genes Chromosomes Cancer. 2013 Feb;52(2):126-39. doi: 10.1002/gcc.22012. Epub 2012 Sep 25.
|
| 813 |
Expression in bladder transitional cell carcinoma by real-time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1-2: identification of 5 candidates tumor suppressor genes.Int J Cancer. 2004 Sep 10;111(4):539-42. doi: 10.1002/ijc.20283.
|
| 814 |
Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.Dis Markers. 2018 Sep 19;2018:4272064. doi: 10.1155/2018/4272064. eCollection 2018.
|
| 815 |
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.Clin Cancer Res. 2000 Nov;6(11):4422-31.
|
| 816 |
Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis.Onco Targets Ther. 2018 Dec 31;12:349-358. doi: 10.2147/OTT.S186065. eCollection 2019.
|
| 817 |
Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.Int J Oncol. 2013 Apr;42(4):1249-56. doi: 10.3892/ijo.2013.1802. Epub 2013 Jan 29.
|
| 818 |
Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.Eur J Cancer. 2011 May;47(7):1106-14. doi: 10.1016/j.ejca.2010.12.025. Epub 2011 Jan 25.
|
| 819 |
A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells In Vitro.Int J Biol Sci. 2019 May 11;15(6):1276-1286. doi: 10.7150/ijbs.32332. eCollection 2019.
|
| 820 |
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study.J Urol. 2017 Jun;197(6):1410-1418. doi: 10.1016/j.juro.2016.12.096. Epub 2016 Dec 31.
|
| 821 |
P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.World J Surg Oncol. 2018 Oct 15;16(1):206. doi: 10.1186/s12957-018-1507-2.
|
| 822 |
Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.Mol Biol Rep. 2013 May;40(5):3799-805. doi: 10.1007/s11033-012-2458-2. Epub 2013 Jan 3.
|
| 823 |
PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.Biochem J. 2017 Mar 24;474(8):1333-1346. doi: 10.1042/BCJ20160875.
|
| 824 |
PBOV1 correlates with progression of ovarian cancer and inhibits proliferation of ovarian cancer cells.Oncol Rep. 2016 Jan;35(1):488-96. doi: 10.3892/or.2015.4396. Epub 2015 Nov 4.
|
| 825 |
Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer.J Int Med Res. 2012;40(6):2117-23. doi: 10.1177/030006051204000609.
|
| 826 |
p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer.J Cancer. 2019 Oct 15;10(25):6207-6216. doi: 10.7150/jca.37335. eCollection 2019.
|
| 827 |
Association between protocadherin 8 promoter hypermethylation and the pathological status of prostate cancer.Oncol Lett. 2017 Aug;14(2):1657-1664. doi: 10.3892/ol.2017.6282. Epub 2017 May 31.
|
| 828 |
miRNA?6a?p and miR?6b?p inhibit the proliferation of bladder cancer cells by regulating PDCD10.Oncol Rep. 2018 Dec;40(6):3523-3532. doi: 10.3892/or.2018.6734. Epub 2018 Sep 26.
|
| 829 |
The Regulatory Role of Non-coding RNAs on Programmed Cell Death Four in Inflammation and Cancer.Front Oncol. 2019 Sep 18;9:919. doi: 10.3389/fonc.2019.00919. eCollection 2019.
|
| 830 |
Prognostic value of PDCD6 polymorphisms and the susceptibility to bladder cancer.Tumour Biol. 2014 Aug;35(8):7547-54. doi: 10.1007/s13277-014-2010-1. Epub 2014 May 3.
|
| 831 |
The Inhibitory Effect of PDIA6 Downregulation on Bladder Cancer Cell Proliferation and Invasion.Oncol Res. 2017 Apr 14;25(4):587-593. doi: 10.3727/096504016X14761811155298. Epub 2016 Oct 18.
|
| 832 |
The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.Mol Cancer Ther. 2018 Sep;17(9):2004-2012. doi: 10.1158/1535-7163.MCT-18-0063. Epub 2018 Jun 15.
|
| 833 |
Construction of a recombinant eukaryotic expression plasmid containing human PDLIM2 gene and its biological activity.Plasmid. 2011 Jul;66(2):106-11. doi: 10.1016/j.plasmid.2011.06.005. Epub 2011 Jul 19.
|
| 834 |
MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer.PLoS One. 2015 Feb 23;10(2):e0118086. doi: 10.1371/journal.pone.0118086. eCollection 2015.
|
| 835 |
Genetic alteration in phosphofructokinase family promotes growth of muscle-invasive bladder cancer.Int J Biol Markers. 2016 Jul 30;31(3):e286-93. doi: 10.5301/jbm.5000189.
|
| 836 |
Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models.Oncotarget. 2016 Oct 25;7(43):70750-70768. doi: 10.18632/oncotarget.12218.
|
| 837 |
Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.J Proteomics. 2016 Jan 30;132:85-92. doi: 10.1016/j.jprot.2015.11.027. Epub 2015 Dec 3.
|
| 838 |
Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.Gene. 2018 Nov 30;677:189-197. doi: 10.1016/j.gene.2018.07.041. Epub 2018 Jul 17.
|
| 839 |
LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.Cancer Med. 2020 Jan;9(2):724-736. doi: 10.1002/cam4.2684. Epub 2019 Nov 25.
|
| 840 |
The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma.Adv Clin Exp Med. 2018 Aug;27(8):1025-1031. doi: 10.17219/acem/71080.
|
| 841 |
Dual Inhibition of PIK3C3 and FGFR as a New Therapeutic Approach to Treat Bladder Cancer.Clin Cancer Res. 2018 Mar 1;24(5):1176-1189. doi: 10.1158/1078-0432.CCR-17-2066. Epub 2017 Dec 8.
|
| 842 |
p85 Inactivates MMP-2 and Suppresses Bladder Cancer Invasion by Inhibiting MMP-14 Transcription and TIMP-2 Degradation.Neoplasia. 2019 Sep;21(9):908-920. doi: 10.1016/j.neo.2019.07.007. Epub 2019 Aug 8.
|
| 843 |
Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer.Urology. 2012 Jan;79(1):240.e1-8. doi: 10.1016/j.urology.2011.08.049. Epub 2011 Nov 25.
|
| 844 |
RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line.Cancer Genet Cytogenet. 2010 Jul 15;200(2):110-9. doi: 10.1016/j.cancergencyto.2010.01.021.
|
| 845 |
Apoptin induces apoptosis in human bladder cancer EJ and BIU-87 cells.Asian Pac J Cancer Prev. 2012;13(1):135-8. doi: 10.7314/apjcp.2012.13.1.135.
|
| 846 |
Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.Kidney Int. 2019 Dec;96(6):1417-1421. doi: 10.1016/j.kint.2019.08.020. Epub 2019 Sep 3.
|
| 847 |
Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Gurin response in patients with high-grade non-muscle-invasive bladder carcinoma.Eur Urol. 2013 Feb;63(2):364-70. doi: 10.1016/j.eururo.2012.05.050. Epub 2012 Jun 5.
|
| 848 |
Overexpressed DNA polymerase iota regulated by JNK/c-Jun contributes to hypermutagenesis in bladder cancer.PLoS One. 2013 Jul 26;8(7):e69317. doi: 10.1371/journal.pone.0069317. Print 2013.
|
| 849 |
An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese.Oncotarget. 2016 Jan 19;7(3):2754-64. doi: 10.18632/oncotarget.6666.
|
| 850 |
Variations in CYP isoforms and bladder cancer: a superfamily paradigm.Urol Oncol. 2014 Jan;32(1):28.e33-40. doi: 10.1016/j.urolonc.2012.10.005. Epub 2013 Feb 19.
|
| 851 |
miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.Tumour Biol. 2016 Apr;37(4):4331-41. doi: 10.1007/s13277-015-4117-4. Epub 2015 Oct 23.
|
| 852 |
Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer.Cancer Genet Cytogenet. 1997 Feb;93(2):167-71. doi: 10.1016/s0165-4608(96)00200-2.
|
| 853 |
Genetic Variations in the 3'-untranslated Regions of Genes Involved in the Cell Cycle and Apoptosis Pathways Affect Bladder Cancer Risk.Cancer Genomics Proteomics. 2018 Jan-Feb;15(1):67-72. doi: 10.21873/cgp.20066.
|
| 854 |
Prima-1 induces apoptosis in bladder cancer cell lines by activating p53.Clinics (Sao Paulo). 2013;68(3):297-303. doi: 10.6061/clinics/2013(03)oa03.
|
| 855 |
BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells.Cancer Med. 2019 Aug;8(10):4792-4805. doi: 10.1002/cam4.2385. Epub 2019 Jun 28.
|
| 856 |
Identifying Cancer Driver lncRNAs Bridged by Functional Effectors through Integrating Multi-omics Data in Human Cancers.Mol Ther Nucleic Acids. 2019 Sep 6;17:362-373. doi: 10.1016/j.omtn.2019.05.030. Epub 2019 Jun 13.
|
| 857 |
KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.DNA Cell Biol. 2002 Oct;21(10):707-15. doi: 10.1089/104454902760599681.
|
| 858 |
Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29.
|
| 859 |
Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis.Mol Cancer. 2018 Oct 3;17(1):144. doi: 10.1186/s12943-018-0892-z.
|
| 860 |
Rab11 Functions as an Oncoprotein via Nuclear Factor kappa B (NF-B) Signaling Pathway in Human Bladder Carcinoma.Med Sci Monit. 2018 Jul 22;24:5093-5101. doi: 10.12659/MSM.911454.
|
| 861 |
Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3/Snail signaling.Carcinogenesis. 2013 Oct;34(10):2401-8. doi: 10.1093/carcin/bgt187. Epub 2013 May 30.
|
| 862 |
Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-B signaling.Oncotarget. 2017 Sep 8;8(43):75272-75283. doi: 10.18632/oncotarget.20775. eCollection 2017 Sep 26.
|
| 863 |
Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties.Cancer Res. 2014 Oct 15;74(20):5758-71. doi: 10.1158/0008-5472.CAN-13-3512. Epub 2014 Sep 26.
|
| 864 |
Inhibition of miR-1247 on cell proliferation and invasion in bladder cancer through its downstream target of RAB36.J Biosci. 2018 Jun;43(2):365-373.
|
| 865 |
RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.Exp Cell Res. 2018 Jan 15;362(2):349-361. doi: 10.1016/j.yexcr.2017.11.036. Epub 2017 Dec 6.
|
| 866 |
MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer.Biomed Pharmacother. 2016 May;80:268-275. doi: 10.1016/j.biopha.2016.03.026. Epub 2016 Apr 1.
|
| 867 |
Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer.J Urol. 2008 Jan;179(1):346-52. doi: 10.1016/j.juro.2007.08.091. Epub 2007 Nov 19.
|
| 868 |
RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.Cell Signal. 2018 Aug;48:38-44. doi: 10.1016/j.cellsig.2018.04.006. Epub 2018 Apr 24.
|
| 869 |
CpG hypermethylation of cellular retinol-binding protein 1 contributes to cell proliferation and migration in bladder cancer.Int J Oncol. 2010 Dec;37(6):1379-88. doi: 10.3892/ijo_00000789.
|
| 870 |
Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.Br J Cancer. 2016 Feb 2;114(3):305-13. doi: 10.1038/bjc.2015.444. Epub 2016 Jan 7.
|
| 871 |
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.Oncotarget. 2016 Nov 15;7(46):76140-76150. doi: 10.18632/oncotarget.12683.
|
| 872 |
Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma.Tumour Biol. 2015 Dec;36(12):9579-88. doi: 10.1007/s13277-015-3721-7. Epub 2015 Jul 4.
|
| 873 |
Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia.J Urol. 2004 Jun;171(6 Pt 1):2330-5. doi: 10.1097/01.ju.0000127760.87421.e9.
|
| 874 |
Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.Sci Rep. 2016 Feb 12;6:20894. doi: 10.1038/srep20894.
|
| 875 |
Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy.Oncotarget. 2016 Feb 23;7(8):8956-67. doi: 10.18632/oncotarget.6909.
|
| 876 |
RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.Oncol Rep. 2016 Feb;35(2):1195-203. doi: 10.3892/or.2015.4409. Epub 2015 Nov 11.
|
| 877 |
MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma.Oncol Rep. 2017 Feb;37(2):1227-1234. doi: 10.3892/or.2016.5290. Epub 2016 Dec 5.
|
| 878 |
Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.Mol Med Rep. 2016 Jun;13(6):4872-8. doi: 10.3892/mmr.2016.5127. Epub 2016 Apr 14.
|
| 879 |
C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation.J Transl Med. 2016 Feb 23;14:55. doi: 10.1186/s12967-016-0801-4.
|
| 880 |
Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.Eur Urol. 2016 Oct;70(4):611-620. doi: 10.1016/j.eururo.2016.02.056. Epub 2016 Mar 15.
|
| 881 |
Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.Tumour Biol. 2016 Apr;37(4):4621-31. doi: 10.1007/s13277-015-4264-7. Epub 2015 Oct 27.
|
| 882 |
S100A16 regulated by Snail promotes the chemoresistance of nonmuscle invasive bladder cancer through the AKT/Bcl-2 pathway.Cancer Manag Res. 2019 Mar 27;11:2449-2456. doi: 10.2147/CMAR.S196450. eCollection 2019.
|
| 883 |
Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours.J Cancer Res Clin Oncol. 2007 Apr;133(4):253-61. doi: 10.1007/s00432-006-0164-y. Epub 2006 Nov 29.
|
| 884 |
HAF drives the switch of HIF-1 to HIF-2 by activating the NF-B pathway, leading to malignant behavior of T24 bladder cancer cells.Int J Oncol. 2014 Feb;44(2):393-402. doi: 10.3892/ijo.2013.2210. Epub 2013 Dec 6.
|
| 885 |
Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals.Clin Chem Lab Med. 2009;47(9):1125-32. doi: 10.1515/CCLM.2009.261.
|
| 886 |
Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer.Exp Ther Med. 2019 Nov;18(5):3475-3483. doi: 10.3892/etm.2019.7960. Epub 2019 Aug 29.
|
| 887 |
SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-RI.Mol Carcinog. 2017 Oct;56(10):2332-2341. doi: 10.1002/mc.22687. Epub 2017 Jun 30.
|
| 888 |
SETD6 regulates NF-B signaling in urothelial cell survival: Implications for bladder cancer.Oncotarget. 2017 Feb 28;8(9):15114-15125. doi: 10.18632/oncotarget.14750.
|
| 889 |
DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection.BMC Cancer. 2008 Aug 14;8:238. doi: 10.1186/1471-2407-8-238.
|
| 890 |
MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression.Cell Physiol Biochem. 2017;41(3):1179-1188. doi: 10.1159/000464379. Epub 2017 Mar 6.
|
| 891 |
Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients.Int J Urol. 2004 Jan;11(1):38-43. doi: 10.1111/j.1442-2042.2004.00739.x.
|
| 892 |
Glucocorticoid-Inducible Kinase 2 Promotes Bladder Cancer Cell Proliferation, Migration and Invasion by Enhancing -catenin/c-Myc Signaling Pathway.J Cancer. 2018 Dec 10;9(24):4774-4782. doi: 10.7150/jca.25811. eCollection 2018.
|
| 893 |
Evaluation of 4-bp insertion/deletion polymorphism within the 3'UTR of SGSM3 in bladder cancer using mismatch PCR-RFLP method: A preliminary report.J Cell Biochem. 2018 Aug;119(8):6566-6574. doi: 10.1002/jcb.26764. Epub 2018 Apr 25.
|
| 894 |
SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.Clin Cancer Res. 2015 Dec 15;21(24):5601-11. doi: 10.1158/1078-0432.CCR-14-3308. Epub 2015 Aug 18.
|
| 895 |
Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.Genomics. 1997 Sep 1;44(2):163-70. doi: 10.1006/geno.1997.4849.
|
| 896 |
Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.FEBS Lett. 2013 Nov 29;587(23):3875-82.
|
| 897 |
High expression of spindle and kinetochore- associated protein 1 predicts early recurrence and progression of non-muscle invasive bladder cancer.Cancer Biomark. 2018;22(3):543-549. doi: 10.3233/CBM-181202.
|
| 898 |
Expression of proteins FGFR3, PI3K, AKT, p21Waf1/Cip1 and cyclins D1 and D3 in patients with T1 bladder tumours: clinical implications and prognostic significance.Actas Urol Esp. 2017 Apr;41(3):172-180. doi: 10.1016/j.acuro.2016.09.003. Epub 2016 Oct 7.
|
| 899 |
When the guardian sleeps: Reactivation of the p53 pathway in cancer.Mutat Res Rev Mutat Res. 2017 Jul;773:1-13. doi: 10.1016/j.mrrev.2017.02.003. Epub 2017 Feb 17.
|
| 900 |
Diagnostic value of smoothelin and vimentin in differentiating muscularis propria from muscularis mucosa of bladder carcinoma.Int J Biol Markers. 2017 Jul 24;32(3):e305-e312. doi: 10.5301/jbm.5000252.
|
| 901 |
Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):848-854. doi: 10.1007/s00259-018-4208-8. Epub 2019 Jan 9.
|
| 902 |
Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer.Mutat Res. 2009 Feb 10;661(1-2):85-92. doi: 10.1016/j.mrfmmm.2008.11.009. Epub 2008 Nov 25.
|
| 903 |
Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.Cell Death Dis. 2018 Oct 11;9(10):1042. doi: 10.1038/s41419-018-1090-z.
|
| 904 |
A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer.APMIS. 2017 Sep;125(9):787-796. doi: 10.1111/apm.12719. Epub 2017 Jun 6.
|
| 905 |
Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11.Mol Med. 2018 Jul 31;24(1):40. doi: 10.1186/s10020-018-0039-0.
|
| 906 |
Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.BMC Cancer. 2018 Jun 7;18(1):642. doi: 10.1186/s12885-018-4560-x.
|
| 907 |
SOX4 regulates invasion of bladder cancer cells via repression of WNT5a.Int J Oncol. 2019 Aug;55(2):359-370. doi: 10.3892/ijo.2019.4832. Epub 2019 Jun 26.
|
| 908 |
Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma.PLoS One. 2013 Dec 9;8(12):e81348. doi: 10.1371/journal.pone.0081348. eCollection 2013.
|
| 909 |
Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.Cancer Biomark. 2019;26(3):281-289. doi: 10.3233/CBM-182143.
|
| 910 |
Steroid receptor coactivator-3 regulates glucose metabolism in bladder cancer cells through coactivation of hypoxia inducible factor 1.J Biol Chem. 2014 Apr 18;289(16):11219-11229. doi: 10.1074/jbc.M113.535989. Epub 2014 Feb 28.
|
| 911 |
Sorcin a Potential Molecular Target for Cancer Therapy.Transl Oncol. 2018 Dec;11(6):1379-1389. doi: 10.1016/j.tranon.2018.08.015. Epub 2018 Sep 11.
|
| 912 |
Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.Biochem Biophys Res Commun. 2012 Jan 6;417(1):588-93. doi: 10.1016/j.bbrc.2011.12.011. Epub 2011 Dec 9.
|
| 913 |
Oxidative damage and response to Bacillus Calmette-Gurin in bladder cancer cells expressing sialyltransferase ST3GAL1.BMC Cancer. 2018 Feb 17;18(1):198. doi: 10.1186/s12885-018-4107-1.
|
| 914 |
Epigenetic inactivation of ST6GAL1 in human bladder cancer.BMC Cancer. 2014 Dec 2;14:901. doi: 10.1186/1471-2407-14-901.
|
| 915 |
Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Gurin (BCG) and to oxidative damage.Oncotarget. 2017 Apr 17;8(33):54506-54517. doi: 10.18632/oncotarget.17138. eCollection 2017 Aug 15.
|
| 916 |
Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts.Elife. 2017 Jul 10;6:e26980. doi: 10.7554/eLife.26980.
|
| 917 |
The role of STAG2 in bladder cancer.Pharmacol Res. 2018 May;131:143-149. doi: 10.1016/j.phrs.2018.02.025. Epub 2018 Mar 1.
|
| 918 |
Biophysical Characterization of SG2NA Variants and their Interaction with DJ-1 and Calmodulin in vitro.Cell Biochem Biophys. 2018 Dec;76(4):451-461. doi: 10.1007/s12013-018-0854-5. Epub 2018 Aug 21.
|
| 919 |
The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression.DNA Cell Biol. 2011 Nov;30(11):851-64. doi: 10.1089/dna.2011.1315. Epub 2011 Jul 8.
|
| 920 |
Stratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer.Mod Pathol. 2015 Apr;28(4):515-22. doi: 10.1038/modpathol.2014.145. Epub 2014 Nov 14.
|
| 921 |
TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers.Epigenetics. 2011 Sep 1;6(9):1120-30. doi: 10.4161/epi.6.9.16376. Epub 2011 Sep 1.
|
| 922 |
Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma.Oncotarget. 2016 Jul 26;7(30):47186-47200. doi: 10.18632/oncotarget.9706.
|
| 923 |
Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.Mol Cancer Ther. 2019 Nov;18(11):1947-1960. doi: 10.1158/1535-7163.MCT-18-1166. Epub 2019 Aug 14.
|
| 924 |
Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.Tumour Biol. 2016 Jun;37(6):7757-65. doi: 10.1007/s13277-015-4567-8. Epub 2015 Dec 22.
|
| 925 |
Long non-coding RNA DILC suppresses bladder cancer cells progression.Gene. 2019 Aug 20;710:193-201. doi: 10.1016/j.gene.2019.06.009. Epub 2019 Jun 7.
|
| 926 |
MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer.J Biochem Mol Toxicol. 2019 Apr;33(4):e22275. doi: 10.1002/jbt.22275. Epub 2018 Dec 10.
|
| 927 |
Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer.Anticancer Res. 2018 Aug;38(8):4607-4615. doi: 10.21873/anticanres.12765.
|
| 928 |
Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.Int J Oncol. 2012 Apr;40(4):951-9. doi: 10.3892/ijo.2011.1294. Epub 2011 Dec 13.
|
| 929 |
Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.Hum Immunol. 2012 Jun;73(6):668-72. doi: 10.1016/j.humimm.2012.03.006. Epub 2012 Apr 12.
|
| 930 |
Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer.Int J Oncol. 2011 Sep;39(3):727-33. doi: 10.3892/ijo.2011.1049. Epub 2011 May 23.
|
| 931 |
TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPAR-SIRT1 feedback loop in human bladder cancer cells.Cancer Lett. 2018 Feb 1;414:278-293. doi: 10.1016/j.canlet.2017.11.015. Epub 2017 Nov 24.
|
| 932 |
Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.Urol Oncol. 2018 Jul;36(7):342.e15-342.e23. doi: 10.1016/j.urolonc.2018.04.001. Epub 2018 Apr 26.
|
| 933 |
Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.J Natl Cancer Inst. 2015 Sep 14;107(11):djv223. doi: 10.1093/jnci/djv223. Print 2015 Nov.
|
| 934 |
High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.J Transl Med. 2018 Jan 19;16(1):9. doi: 10.1186/s12967-017-1377-3.
|
| 935 |
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.World J Urol. 2018 Nov;36(11):1719-1725. doi: 10.1007/s00345-018-2334-3. Epub 2018 May 16.
|
| 936 |
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.Int J Cancer. 2004 May 1;109(5):786-92. doi: 10.1002/ijc.20041.
|
| 937 |
Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.BMC Cancer. 2009 May 11;9:140. doi: 10.1186/1471-2407-9-140.
|
| 938 |
GPI transamidase and GPI anchored proteins: oncogenes and biomarkers for cancer.Crit Rev Biochem Mol Biol. 2013 Sep-Oct;48(5):446-64. doi: 10.3109/10409238.2013.831024. Epub 2013 Aug 27.
|
| 939 |
Gain of 5p15.33 is associated with progression of bladder cancer.Oncology. 2007;72(1-2):132-8. doi: 10.1159/000111132. Epub 2007 Nov 15.
|
| 940 |
ATDC mediates a TP63-regulated basal cancer invasive program.Oncogene. 2019 May;38(18):3340-3354. doi: 10.1038/s41388-018-0646-9. Epub 2019 Jan 14.
|
| 941 |
TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.Am J Pathol. 2004 Jul;165(1):63-9. doi: 10.1016/S0002-9440(10)63275-0.
|
| 942 |
An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.Urol Oncol. 2012 Jul-Aug;30(4):502-8. doi: 10.1016/j.urolonc.2010.02.013. Epub 2010 Sep 22.
|
| 943 |
Hsa-miR-429 promotes bladder cancer cell proliferation via inhibiting CDKN2B.Oncotarget. 2017 Aug 3;8(40):68721-68729. doi: 10.18632/oncotarget.19878. eCollection 2017 Sep 15.
|
| 944 |
Allele-specific methylation analysis on upstream promoter region of H19 by methylation-specific PCR with confronting two-pair primers.Int J Oncol. 2004 Nov;25(5):1273-8.
|
| 945 |
Expression of type-IV collagenases in human tumor cell lines that can form liver colonies in chick embryos.Int J Cancer. 1994 Jan 2;56(1):46-51. doi: 10.1002/ijc.2910560109.
|
| 946 |
N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines.Cancer Lett. 2002 Jun 28;180(2):131-7. doi: 10.1016/s0304-3835(01)00864-3.
|
| 947 |
miR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5.Oncol Res. 2017 Aug 7;25(7):1081-1087. doi: 10.3727/096504016X14831120463349. Epub 2017 Jan 20.
|
| 948 |
Significance of suppressor of cytokine signaling-3 expression in bladder urothelial carcinoma in relation to proinflammatory cytokines and tumor histopathological grading.Asian Pac J Cancer Prev. 2015;16(1):307-14. doi: 10.7314/apjcp.2015.16.1.307.
|
| 949 |
Significant antitumoral activity of cationic multilamellar liposomes containing human IFN-beta gene against human renal cell carcinoma.Clin Cancer Res. 2003 Mar;9(3):1129-35.
|
| 950 |
Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004 Mar 3;96(5):357-63. doi: 10.1093/jnci/djh058.
|
| 951 |
Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.Cancer Lett. 2005 Jul 8;225(1):121-30. doi: 10.1016/j.canlet.2004.10.047. Epub 2004 Dec 10.
|
| 952 |
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts.BMC Cancer. 2010 Nov 24;10:646. doi: 10.1186/1471-2407-10-646.
|
| 953 |
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer.Eur Urol. 2010 Sep;58(3):433-41. doi: 10.1016/j.eururo.2010.05.043. Epub 2010 Jun 9.
|
| 954 |
Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression.Clin Biochem. 2004 Dec;37(12):1098-104. doi: 10.1016/j.clinbiochem.2004.09.006.
|
| 955 |
Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.Oncogene. 2008 Nov 6;27(52):6679-89. doi: 10.1038/onc.2008.264. Epub 2008 Aug 25.
|
| 956 |
Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.Cancer Biomark. 2017;18(4):381-387. doi: 10.3233/CBM-160261.
|
| 957 |
Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer.Oncotarget. 2017 May 9;8(19):30844-30858. doi: 10.18632/oncotarget.9602.
|
| 958 |
HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer.Int J Cancer. 2002 Aug 1;100(4):414-8. doi: 10.1002/ijc.10497.
|
| 959 |
DBC2 gene is silenced by promoter methylation in bladder cancer.Urol Oncol. 2008 Sep-Oct;26(5):465-9. doi: 10.1016/j.urolonc.2007.08.009. Epub 2008 Jul 21.
|
| 960 |
HIF-1/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.Oncol Rep. 2016 Mar;35(3):1549-56. doi: 10.3892/or.2015.4536. Epub 2015 Dec 29.
|
| 961 |
Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer.Urology. 2008 Oct;72(4):873-7. doi: 10.1016/j.urology.2007.12.026. Epub 2008 May 15.
|
|
|
|
|
|
|
